← 產業報告目錄

High-Throughput Screening (HTS) Market by Instruments (Liquid Handling, Detection, Imaging), Consumables (Reagents, Kits), Software, Services, Technology (Cell-based, High-content, Label-free), Workflow, Application, Competition - Global Forecast to 2031

出版商 MarketsandMarkets產業別 Healthcare & Life Sciences出版日期 2026-05-20頁數 719報告編號 BT2220

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The high-throughput screening (HTS) market is expected to reach USD 45.90 billion in 2031 from USD 27.66 billion in 2026, growing at a CAGR of 10.7% during the forecast period. Factors such as the rising adoption of open innovation models, increasing government funding and venture capital investments, and higher R&D spending by pharmaceutical and biotechnology companies. Technological advancements in automation, high-content screening, cell-based assays, label-free detection, and AI-enabled data analysis are further improving screening efficiency and supporting wider adoption of HTS platforms across drug discovery workflows. By offering, the products segment accounted for the largest share of the high-throughput screening (HTS) market in 2025. Based on offering, the high-throughput screening (HTS) market is segmented into products and services. In 2025, the products segment held the largest share of the high-throughput screening (HTS) market. This is driven by recurring demand for assay kits, reagents, consumables, microplates, compound libraries, instruments, software, and automation platforms. The segment remains dominant because HTS workflows require continuous use of consumables and integrated instruments throughout assay development, screening, data analysis, and hit confirmation. Strong adoption of automated liquid handlers, microplate readers, high-content imaging systems, and assay-ready kits further supports the revenue contribution of products in the HTS market. By application, the drug discovery & development segment accounted for the largest share of the high-throughput screening (HTS) market in 2025. By application, the high-throughput screening (HTS) market is divided into drug discovery & development, basic research & functional genomics, toxicology & safety screening, precision medicine & biomarker discovery, stem cell & regenerative medicine research, and other applications. In 2025, the drug discovery & development segment held the largest share of the high-throughput screening (HTS) market, as HTS is widely used to screen large compound libraries, identify hits, validate targets, and support lead optimization. Pharmaceutical and biotechnology companies continue to rely on HTS platforms to improve early-stage discovery productivity and reduce the time required to move candidates into preclinical development. The segment also benefits from the growing use of phenotypic screening, cell-based assays, 3D models, and high-content imaging to identify more biologically relevant drug candidates. The Asia Pacific region is expected to grow at the highest CAGR in the high-throughput screening (HTS) market from 2026 to 2031. The high-throughput screening (HTS) market is divided into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. The Asia Pacific region is expected to grow at a significant CAGR during the forecast period. This increase is driven by expanding pharmaceutical and biotechnology R&D activity, growing CRO presence, and increasing investments in drug discovery infrastructure. Countries such as China, India, Japan, and South Korea are strengthening their screening capabilities through rising research funding, outsourcing demand, and the adoption of automated laboratory technologies. The region is also benefiting from cost-efficient research operations, expanding biotech start-up activity, and increasing partnerships between global pharma companies and local discovery service providers. The primary interviews conducted for this report can be categorized as follows: • By Respondent: Supply Side (80%) and Demand Side (20%) • By Designation: Managers (45%), CXOs & Directors (30%), and Executives (25%) • By Region: North America (40%), Europe (25%), Asia Pacific (25%), Latin America (5%), the Middle East & Africa (5%) Thermo Fisher Scientific Inc. (US), Agilent Technologies, Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), Revvity, Inc. (US), Tecan Group Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), Corning Incorporated (US), Mettler-Toledo International Inc. (US), Lonza Group (Switzerland), Waters Corporation (US), Sartorius AG (Germany), Eppendorf SE (Germany), Porvair Plc (UK), Greiner AG (Austria), Charles River Laboratories (US), Eurofins Scientific (Luxembourg), and Hamilton Company (US) are some of the key companies offering HTS solutions. Research Coverage This research report categorizes the high-throughput screening (HTS) market by offering (products and services), products by type (instruments; reagents, kits, and consumables; software & informatics; and services), products by technology (biochemical screening technologies, cell-based screening technologies, high-content screening (HCS) technologies, label-free screening technologies, microfluidic & miniaturized screening technologies, 3D cell culture & advanced cellular model technologies, ultra-high-throughput & automation technologies, and AI-enabled & computational screening technologies), products by workflow (assay development & optimization, compound library preparation, high-throughput screening, data analysis & hit identification, hit confirmation, hit validation & characterization), products by end user (pharmaceutical & biotechnology companies, CROs & CDMOs, academic & research institutes, and other end users), services by type (assay development & optimization services, compound library management services, primary screening services, secondary screening & hit confirmation services, hit validation & characterization services, data analysis & informatics services, and other services), services by end user (pharmaceutical & biotechnology companies, academic & research institutes, and other end users), application (drug discovery & development, basic research & functional genomics, toxicology & safety screening, precision medicine & biomarker discovery, stem cell & regenerative medicine research, and other applications), and region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The scope of the report provides detailed information on major factors such as drivers, challenges, opportunities, and restraints that influence the growth of the high-throughput screening (HTS) market. A comprehensive analysis of key industry players has been conducted to provide insights into their business overviews, product/service portfolios, and key strategies, including collaborations, partnerships, expansions, agreements, acquisitions, and recent developments in the high-throughput screening (HTS) market. This report includes a competitive analysis of top players and upcoming startups in the high-throughput screening (HTS) market ecosystem. The report also details primary factors like drivers, restraints, challenges, and opportunities shaping the market growth, along with an in-depth review of key industry players’ solutions, products, recent product launches, mergers, acquisitions, and emerging market trends ecosystem. Key Benefits of Buying the Report This report offers a comprehensive overview of the high-throughput screening (HTS) market. It aims to assess the market size and future growth opportunities across various segments. The report also features an in-depth competitive analysis of the major market players, including their company profiles, recent developments, and key market strategies. The report provides insights into the following pointers: Analysis of key drivers (growing adoption of open innovative models, growing R&D funding and increasing public & private investments, growing adoption of lab automation and robotic screening platforms, and increasing outsourcing of screening activities to CROs and HTS service providers), restraints (high costs associated with HTS instruments and complexity in assay development and validation), opportunities (increasing adoption of HTS technologies in emerging markets and growing application of HTS in drug repurposing and personalized medicine), and challenges (complexity in data management & analysis, standardization challenges in 3D, organoid, and image-based assays) • Product/Service Development/Innovation: Detailed insights on newly launched products/services, and technological assessment of the high-throughput screening (HTS) market. • Market Development: Comprehensive information about lucrative markets; the report analyzes the high-throughput screening (HTS) market across varied regions. • Market Diversification: Exhaustive information about new, untapped geographies, recent developments, and investments in the high-throughput screening (HTS) market Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players such as Thermo Fisher Scientific Inc. (US), Agilent Technologies, Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), Revvity, Inc. (US), Tecan Group Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), Corning Incorporated (US), Mettler-Toledo International Inc. (US), Lonza Group (Switzerland), Waters Corporation (US), Sartorius AG (Germany), Eppendorf SE (Germany), Porvair Plc (UK), Greiner AG (Austria), Charles River Laboratories (US), Eurofins Scientific (Luxembourg), and Hamilton Company (US), among others, in the high-throughput screening (HTS) market. The report also helps stakeholders understand trends in the high-throughput screening (HTS) market and provides information on key drivers, restraints, challenges, and opportunities. A detailed analysis of the key industry players has been conducted to offer insights into their strategies, product/service launches, acquisitions, partnerships, collaborations, recent activities, investments, funding, brand and product comparisons, vendor evaluations, and financial metrics of the HTS sector market.
目錄 Table of Contents
1 INTRODUCTION 60 1.1 STUDY OBJECTIVES 60 1.2 MARKET DEFINITION 60 1.3 STUDY SCOPE 60 1.3.1 MARKET SEGMENTATION & REGIONS COVERED 61 1.3.2 INCLUSIONS & EXCLUSIONS 62 1.3.3 YEARS CONSIDERED 64 1.3.4 CURRENCY CONSIDERED 64 1.4 STAKEHOLDERS 64 1.5 SUMMARY OF CHANGES 65 2 EXECUTIVE SUMMARY 66 2.1 MARKET HIGHLIGHTS & KEY INSIGHTS 66 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 67 2.3 DISRUPTIVE TRENDS IN HIGH-THROUGHPUT SCREENING MARKET 68 2.4 HIGH-GROWTH SEGMENTS 69 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 70 3 PREMIUM INSIGHTS 72 3.1 HIGH-THROUGHPUT SCREENING MARKET OVERVIEW 72 3.2 NORTH AMERICA: HIGH-THROUGHPUT SCREENING MARKET, BY PRODUCT TYPE AND COUNTRY 73 3.3 HIGH-THROUGHPUT SCREENING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 74 3.4 HIGH-THROUGHPUT SCREENING PRODUCTS MARKET SHARE, BY END USER, 2026 VS 2031 (%) 75 4 MARKET OVERVIEW 76 4.1 INTRODUCTION 76 4.2 MARKET DYNAMICS 77 4.2.1 DRIVERS 78 4.2.1.1 Growing adoption of open innovative models 78 4.2.1.2 Technological advancements 78 4.2.1.3 Growing R&D funding and increasing public & private investments 79 4.2.1.4 Growing adoption of lab automation & robotic screening platforms 79 4.2.1.5 Increasing outsourcing of screening activities to CROs & CDMOs 80 4.2.2 RESTRAINTS 81 4.2.2.1 High costs associated with HTS instruments 81 4.2.2.2 Complexity in assay development and validation 81 4.2.3 OPPORTUNITIES 82 4.2.3.1 Increasing adoption of HTS technologies in emerging markets 82 4.2.3.2 Growing application of HTS in drug repurposing and personalized medicine 82 4.2.3.3 Expansion of CRISPR, RNAi, and functional genomics screening 82 4.2.4 CHALLENGES 83 4.2.4.1 Complexity in data management and analysis 83 4.3 UNMET NEEDS & WHITE SPACES 83 4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 84 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 85 5 INDUSTRY TRENDS 86 5.1 PORTER’S FIVE FORCES ANALYSIS 86 5.1.1 INTENSITY OF COMPETITIVE RIVALRY 87 5.1.2 BARGAINING POWER OF SUPPLIERS 87 5.1.3 BARGAINING POWER OF BUYERS 87 5.1.4 THREAT OF SUBSTITUTES 87 5.1.5 THREAT OF NEW ENTRANTS 88 5.2 MACROECONOMIC OUTLOOK 88 5.2.1 INTRODUCTION 88 5.2.2 GDP TRENDS & FORECAST 88 5.2.3 TRENDS IN GLOBAL HIGH-THROUGHPUT SCREENING INDUSTRY 89 5.3 VALUE CHAIN ANALYSIS 89 5.4 ECOSYSTEM ANALYSIS 91 5.5 PRICING ANALYSIS 93 5.5.1 AVERAGE SELLING PRICE TREND OF HTS PRODUCTS, BY KEY PLAYER, 2023–2025 93 5.5.2 AVERAGE SELLING PRICE TREND OF HTS PRODUCTS, BY REGION, 2023–2025 95 5.6 TRADE ANALYSIS 96 5.6.1 IMPORT SCENARIO (HS CODE 902730 & 902781) 96 5.6.2 EXPORT SCENARIO (HS CODE 902730& 902781) 99 5.7 KEY CONFERENCES & EVENTS, 2026–2027 102 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 103 5.9 INVESTMENT & FUNDING SCENARIO 103 5.10 IMPACT OF 2025 US TARIFFS ON HIGH-THROUGHPUT SCREENING (HTS) MARKET 104 5.10.1 INTRODUCTION 104 5.10.2 KEY TARIFF RATES 105 5.10.3 PRICE IMPACT ANALYSIS 106 5.10.4 IMPACT ON COUNTRIES/REGIONS 106 5.10.4.1 US 106 5.10.4.2 Europe 107 5.10.4.3 Asia Pacific 107   5.10.5 IMPACT ON END-USE INDUSTRIES 107 5.10.5.1 Pharmaceutical & biotechnology companies 108 5.10.5.2 CROs & CDMOs 108 5.10.5.3 Academic & research institutes 108 6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, AND INNOVATIONS 109 6.1 TECHNOLOGICAL ANALYSIS 109 6.1.1 KEY EMERGING TECHNOLOGIES 109 6.1.1.1 High-content screening 109 6.1.1.2 Label-free detection 109 6.1.1.3 Microfluidics 110 6.1.2 COMPLEMENTARY TECHNOLOGIES 110 6.1.2.1 Laboratory automation & robotic integration 110 6.1.2.2 Mass spectrometry 110 6.1.2.3 Flow cytometry 110 6.1.3 ADJACENT TECHNOLOGIES 111 6.1.3.1 Fragment-based drug discovery 111 6.1.3.2 Bioinformatics & cheminformatics 111 6.2 TECHNOLOGY/PRODUCT ROADMAP 112 6.3 PATENT ANALYSIS 112 6.3.1 TOP APPLICANTS/OWNERS (COMPANIES) FOR HIGH-THROUGHPUT SCREENING PATENTS, 2015–2025 113 6.4 FUTURE APPLICATIONS 115 6.5 IMPACT OF AI/GEN AI ON HIGH-THROUGHPUT SCREENING (HTS) MARKET 116 6.5.1 BEST PRACTICES IN HTS WORKFLOW 117 6.5.2 CASE STUDIES OF AI IMPLEMENTATION IN HIGH-THROUGHPUT SCREENING (HTS) MARKET 118 6.5.3 INTERCONNECTED ADJACENT ECOSYSTEMS & IMPACT ON MARKET PLAYERS 119 6.5.4 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN HIGH-THROUGHPUT SCREENING (HTS) MARKET 119 7 SUSTAINABILITY & REGULATORY LANDSCAPE 120 7.1 REGIONAL REGULATIONS & COMPLIANCE 120 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 120 7.1.2 INDUSTRY STANDARDS 122 7.2 SUSTAINABILITY INITIATIVES 124 7.3 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES 124 7.4 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 124   8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 125 8.1 DECISION-MAKING PROCESS 125 8.2 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA 125 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 125 8.2.2 KEY BUYING CRITERIA, BY END USER 126 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 127 8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 127 8.5 MARKET PROFITABILITY 128 9 HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING 129 9.1 INTRODUCTION 130 9.2 PRODUCTS 130 9.2.1 RECURRING CONSUMABLES DEMAND, AUTOMATION UPGRADES, AND ADVANCED SCREENING PLATFORMS TO DRIVE MARKET GROWTH 130 9.3 SERVICES 134 9.3.1 RISING OUTSOURCING OF ASSAY DEVELOPMENT, PRIMARY SCREENING, AND DATA ANALYSIS TO DRIVE GROWTH OF HTS SERVICES MARKET 134 10 HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE 138 10.1 INTRODUCTION 139 10.2 REAGENTS, KITS, AND CONSUMABLES 139 10.2.1 SCREENING ASSAY KITS 143 10.2.1.1 Cell-based assays 146 10.2.1.1.1 Cell viability assays 149 10.2.1.1.1.1 Increasing use of viability readouts across oncology and toxicity screening to sustain assay kit demand 149 10.2.1.1.2 Cytotoxicity assays 152 10.2.1.1.2.1 Rising focus on early toxicity detection to improve lead selection and reduce drug development risk 152 10.2.1.1.3 Reporter gene assays 155 10.2.1.1.3.1 Growing use of pathway-specific functional readouts to strengthen reporter gene assay adoption 155 10.2.1.1.4 Other cell-based assays 158 10.2.1.2 Biochemical assays 161 10.2.1.2.1 Enzyme assays 164 10.2.1.2.1.1 Broad use of enzyme activity profiling in target-based drug discovery to sustain demand for enzyme assay kits 164 10.2.1.2.2 Kinase assays 167 10.2.1.2.2.1 Continued investment in targeted kinase inhibitor discovery to drive kinase assay kit demand 167 10.2.1.2.3 Binding assays 169 10.2.1.2.3.1 Rising use of target engagement and affinity profiling to improve hit validation quality 169 10.2.1.2.4 Other biochemical assays 172 10.2.1.3 Other assays & kits 175 10.2.2 BIOLOGICAL & CELL CULTURE REAGENTS 178 10.2.2.1 Rising use of disease-relevant cellular models to strengthen demand for biological and cell culture reagents 178 10.2.3 COMPOUND LIBRARIES 181 10.2.3.1 Expansion of focused and repurpose libraries to support compound library demand 181 10.2.4 DETECTION REAGENTS 184 10.2.4.1 Increasing adoption of fluorescence, luminescence, and biomarker-based readouts to drive detection reagent use 184 10.2.5 3D CELL CULTURE PRODUCTS 186 10.2.5.1 Scaffold-based 3D cell culture products 189 10.2.5.1.1 Rising demand for matrix-supported disease models to drive scaffold-based 3D culture product growth 189 10.2.5.2 Scaffold-free 3D cell culture products 193 10.2.5.2.1 Increasing use of spheroid-based screening to support scaffold-free 3D culture product adoption 193 10.2.5.3 Other 3D cell culture products 196 10.2.6 OTHER HTS CONSUMABLES 199 10.3 INSTRUMENTS 202 10.3.1 DETECTION & IMAGING SYSTEMS 205 10.3.1.1 Microplate readers 208 10.3.1.1.1 Growing use of multiplexed biochemical and cell-based assays to support microplate reader demand 208 10.3.1.2 High-content screening (HCS) & imaging systems 212 10.3.1.2.1 Increasing adoption of phenotypic screening and AI-based cellular analysis to drive growth of HCS systems 212 10.3.1.3 Cell analysis systems 215 10.3.1.3.1 Growing use of cell-based screening and functional biology assays to strengthen demand for cell analysis systems 215 10.3.1.4 Label-free detection systems 218 10.3.1.4.1 Rising need for real-time biomolecular interaction analysis to support adoption of label-free detection systems 218 10.3.1.5 Microfluidic & miniaturized screening systems 221 10.3.1.5.1 Assay miniaturization to drive adoption of microfluidic screening systems 221 10.3.2 LIQUID HANDLING & AUTOMATION SYSTEMS 225 10.3.2.1 Increasing assay miniaturization and workflow standardization to drive growth of liquid handling & automation systems 225 10.3.3 ROBOTIC HTS PLATFORMS & AUTOMATED WORKFLOW SYSTEMS 228 10.3.3.1 Rising deployment of end-to-end laboratory automation systems to accelerate robotic HTS platform adoption 228 10.3.4 OTHER HTS INSTRUMENTS 231 10.4 SOFTWARE & INFORMATICS 234 10.4.1 BIOINFORMATICS TOOLS TO HELP TURN RAW DATA INTO MEANINGFUL INSIGHTS 234 11 HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY 238 11.1 INTRODUCTION 239 11.2 CELL-BASED SCREENING TECHNOLOGIES 240 11.2.1 INCREASING ADOPTION OF PHYSIOLOGICALLY RELEVANT PHENOTYPIC SCREENING WORKFLOWS TO STRENGTHEN CELL-BASED TECHNOLOGY DEMAND 240 11.3 ULTRA-HIGH-THROUGHPUT & AUTOMATION TECHNOLOGIES 243 11.3.1 GROWING DEMAND FOR SCALABLE ROBOTIC INFRASTRUCTURE & INTEGRATED AUTOMATION PLATFORMS TO SUPPORT MARKET GROWTH 243 11.4 HIGH-CONTENT SCREENING (HCS) TECHNOLOGIES 247 11.4.1 RISING ADOPTION OF AI-POWERED PHENOTYPIC IMAGING AND MULTIPARAMETRIC CELLULAR PROFILING TO ACCELERATE HCS TECHNOLOGY GROWTH 247 11.5 BIOCHEMICAL SCREENING TECHNOLOGIES 250 11.5.1 CONTINUED EXPANSION OF TARGET-BASED DRUG DISCOVERY PROGRAMS TO SUSTAIN BIOCHEMICAL SCREENING PRODUCT DEMAND 250 11.6 3D CELL CULTURE & ADVANCED CELLULAR MODEL TECHNOLOGIES 254 11.6.1 RISING ADOPTION OF ORGANOIDS, SPHEROIDS, AND TISSUE-LIKE SCREENING SYSTEMS TO ACCELERATE 3D CELLULAR TECHNOLOGY GROWTH 254 11.7 LABEL-FREE SCREENING TECHNOLOGIES 257 11.7.1 INCREASING USE OF REAL-TIME BINDING KINETICS AND BIOPHYSICAL PROFILING TO SUPPORT LABEL-FREE SCREENING ADOPTION 257 11.8 OTHER HTS TECHNOLOGIES 261 12 HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW 264 12.1 INTRODUCTION 265 12.2 PRIMARY SCREENING 265 12.2.1 LARGE-SCALE COMPOUND SCREENING REQUIREMENTS TO SUSTAIN PRODUCT DEMAND ACROSS PRIMARY HTS WORKFLOWS 265 12.3 ASSAY DEVELOPMENT & OPTIMIZATION 269 12.3.1 RISING NEED FOR ROBUST, MINIATURIZED, AND AUTOMATION-COMPATIBLE ASSAYS TO SUPPORT ASSAY DEVELOPMENT PRODUCT DEMAND 269 12.4 HIT CONFIRMATION/SECONDARY SCREENING 272 12.4.1 RISING FOCUS ON HIT QUALITY ASSESSMENT AND FALSE-POSITIVE REDUCTION TO SUPPORT SECONDARY SCREENING PRODUCT DEMAND 272 12.5 DATA ANALYSIS & HIT IDENTIFICATION 276 12.5.1 INCREASING INTEGRATION OF AI-DRIVEN ANALYTICS AND IMAGE-BASED SCREENING DATA TO ACCELERATE HIT IDENTIFICATION WORKFLOWS 276 12.6 COMPOUND LIBRARY PREPARATION 279 12.6.1 EXPANSION OF LARGE-SCALE AND FOCUSED SCREENING LIBRARIES TO STRENGTHEN DEMAND FOR COMPOUND PREPARATION PRODUCTS 279 12.7 HIT VALIDATION & CHARACTERIZATION 282 12.7.1 GROWING FOCUS ON PHENOTYPIC CHARACTERIZATION WORKFLOWS TO DRIVE HIT VALIDATION PRODUCT DEMAND 282   13 HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER 286 13.1 INTRODUCTION 287 13.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 287 13.2.1 SUSTAINED BIOPHARMA R&D INVESTMENT AND AUTOMATION-LED DRUG DISCOVERY TO DRIVE HTS PRODUCT ADOPTION 287 13.3 CROS & CDMOS 291 13.3.1 RISING DISCOVERY OUTSOURCING AND CRO PLATFORM EXPANSION TO ACCELERATE HTS PRODUCT DEMAND 291 13.4 ACADEMIC & RESEARCH INSTITUTES 294 13.4.1 PUBLIC RESEARCH FUNDING AND TRANSLATIONAL BIOLOGY PROGRAMS TO SUPPORT HTS PRODUCT UPTAKE IN RESEARCH INSTITUTES 294 13.5 OTHER END USERS 298 14 HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE 301 14.1 INTRODUCTION 302 14.2 PRIMARY SCREENING SERVICES 303 14.2.1 RISING HIGH-VOLUME SCREENING REQUIREMENTS TO DRIVE GROWTH OF PRIMARY HTS SCREENING SERVICES 303 14.3 ASSAY DEVELOPMENT & OPTIMIZATION SERVICES 306 14.3.1 INCREASING DEMAND FOR CUSTOMIZED AND MINIATURIZED ASSAYS TO SUPPORT ASSAY DEVELOPMENT SERVICE ADOPTION 306 14.4 SECONDARY SCREENING & HIT CONFIRMATION SERVICES 309 14.4.1 INCREASING EMPHASIS ON HIT VALIDATION AND SELECTIVITY ASSESSMENT TO SUPPORT SECONDARY SCREENING SERVICES 309 14.5 HIT VALIDATION & CHARACTERIZATION SERVICES 312 14.5.1 GROWING NEED FOR MECHANISM-OF-ACTION PROFILING TO STRENGTHEN HIT CHARACTERIZATION SERVICE ADOPTION 312 14.6 COMPOUND LIBRARY MANAGEMENT SERVICES 315 14.6.1 EXPANSION OF LARGE-SCALE SCREENING LIBRARIES TO STRENGTHEN DEMAND FOR COMPOUND MANAGEMENT SERVICES 315 14.7 DATA ANALYSIS & INFORMATICS SERVICES 318 14.7.1 GROWING ADOPTION OF AI-ENABLED SCREENING ANALYTICS AND IMAGE-BASED DATA INTERPRETATION TO DRIVE HTS INFORMATICS SERVICES GROWTH 318 14.8 OTHER HTS SERVICES 322 15 HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER 325 15.1 INTRODUCTION 326 15.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 326 15.2.1 INCREASING COMPLEXITY OF DRUG DISCOVERY WORKFLOWS TO STRENGTHEN OUTSOURCING OF HTS SERVICES BY PHARMA AND BIOTECH COMPANIES 326 15.3 ACADEMIC & RESEARCH INSTITUTES 330 15.3.1 LIMITED IN-HOUSE AUTOMATION CAPACITY TO DRIVE ACADEMIC OUTSOURCING OF HTS SERVICES 330 15.4 OTHER END USERS 333 16 HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION 336 16.1 INTRODUCTION 337 16.2 DRUG DISCOVERY & DEVELOPMENT 338 16.2.1 INCREASING PHARMACEUTICAL R&D INVESTMENTS AND EXPANSION OF TARGET-BASED AND PHENOTYPIC DRUG DISCOVERY PROGRAMS TO DRIVE MARKET GROWTH 338 16.3 BASIC RESEARCH & FUNCTIONAL GENOMICS 341 16.3.1 GROWING ADOPTION OF CRISPR SCREENING, FUNCTIONAL GENOMICS, AND DISEASE PATHWAY CHARACTERIZATION TO DRIVE HTS DEMAND 341 16.4 TOXICOLOGY & SAFETY SCREENING 345 16.4.1 INCREASING EMPHASIS ON PREDICTIVE TOXICOLOGY AND REGULATORY PRESSURE TO REDUCE ANIMAL TESTING TO ACCELERATE HTS ADOPTION 345 16.5 PRECISION MEDICINE & BIOMARKER DISCOVERY 348 16.5.1 EXPANSION OF BIOMARKER-GUIDED THERAPEUTICS AND PERSONALIZED MEDICINE PIPELINES TO DRIVE RAPID GROWTH IN PRECISION MEDICINE SCREENING APPLICATIONS 348 16.6 STEM CELL & REGENERATIVE MEDICINE RESEARCH 351 16.6.1 GROWING DEVELOPMENT OF CELL THERAPIES AND REGENERATIVE MEDICINE PRODUCTS IS SUPPORTING HTS ADOPTION IN STEM CELL RESEARCH 351 16.7 OTHER APPLICATIONS 354 17 HIGH-THROUGHPUT SCREENING MARKET, BY REGION 357 17.1 INTRODUCTION 358 17.2 NORTH AMERICA 359 17.2.1 US 368 17.2.1.1 Advanced automation, strong drug discovery infrastructure, and AI-enabled screening workflows to support market growth 368 17.2.2 CANADA 375 17.2.2.1 Academic screening infrastructure to support market growth 375 17.3 EUROPE 383 17.3.1 GERMANY 392 17.3.1.1 Increasing product launches and investments to boost market growth 392 17.3.2 UK 399 17.3.2.1 Industrial-scale screening access and academic HTS infrastructure to support market 399 17.3.3 FRANCE 406 17.3.3.1 Large pharmaceutical R&D expenditure to drive market growth 406 17.3.4 ITALY 414 17.3.4.1 Functional genomics and automated screening platforms to fuel growth 414 17.3.5 SPAIN 421 17.3.5.1 Academic screening platforms, chemical biology networks, and assay automation to boost market 421 17.3.6 REST OF EUROPE 427 17.4 ASIA PACIFIC 435 17.4.1 CHINA 444 17.4.1.1 Automation-led drug discovery and CRO-led screening capacity expansion to support growth of market 444 17.4.2 JAPAN 451 17.4.2.1 Advanced screening platforms and integrated drug discovery partnerships to support market growth 451 17.4.3 INDIA 458 17.4.3.1 Automation-led CRO expansion and biopharma R&D infrastructure growth to fuel market 458 17.4.4 AUSTRALIA 465 17.4.4.1 Robotic screening infrastructure and translational drug discovery programs to drive market growth 465 17.4.5 SOUTH KOREA 472 17.4.5.1 AI-enhanced screening platforms and translational R&D collaborations to favor market growth 472 17.4.6 REST OF ASIA PACIFIC (ROAPAC) 479 17.5 LATIN AMERICA 486 17.5.1 BRAZIL 494 17.5.1.1 Automated bioassay infrastructure and disease-focused discovery programs to drive growth 494 17.5.2 MEXICO 501 17.5.2.1 Cost-efficient discovery capacity, antimicrobial research, and automated assay adoption to drive growth 501 17.5.3 REST OF LATIN AMERICA 508 17.6 MIDDLE EAST 515 17.6.1 GCC COUNTRIES 522 17.6.1.1 Saudi Arabia 530 17.6.1.1.1 Growing pharmaceuticals industry to support market growth 530 17.6.1.2 UAE 537 17.6.1.2.1 Precision medicine investment, automated laboratory infrastructure, and AI-enabled discovery workflows to boost market growth 537 17.6.1.3 Rest of GCC Countries 544 17.6.2 REST OF MIDDLE EAST 550 17.7 AFRICA 558 17.7.1 INFECTIOUS DISEASE RESEARCH AND SHARED DISCOVERY NETWORKS TO AID MARKET GROWTH 558   18 COMPETITIVE LANDSCAPE 565 18.1 OVERVIEW 565 18.2 KEY PLAYER STRATEGY/RIGHT TO WIN 565 18.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN HIGH-THROUGHPUT SCREENING (HTS) MARKET 566 18.3 REVENUE ANALYSIS, 2021–2025 567 18.4 MARKET SHARE ANALYSIS, 2025 568 18.5 COMPANY EVALUATION QUADRANT: KEY PLAYERS, 2025 571 18.5.1 STARS 571 18.5.2 EMERGING LEADERS 571 18.5.3 PERVASIVE PLAYERS 571 18.5.4 PARTICIPANTS 572 18.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 573 18.5.5.1 Company footprint 573 18.5.5.2 Region footprint 574 18.5.5.3 Offering footprint 575 18.5.5.4 Product type footprint 576 18.5.5.5 Application footprint 577 18.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 578 18.6.1 PROGRESSIVE COMPANIES 578 18.6.2 RESPONSIVE COMPANIES 578 18.6.3 DYNAMIC COMPANIES 578 18.6.4 STARTING BLOCKS 578 18.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 580 18.6.5.1 Detailed list of key startups/SMEs 580 18.6.5.2 Competitive benchmarking of key startups/SMEs 581 18.7 COMPANY VALUATION & FINANCIAL METRICS 581 18.7.1 FINANCIAL METRICS 581 18.7.2 COMPANY VALUATION 582 18.8 BRAND/PRODUCT/SERVICE COMPARISON 583 18.9 COMPETITIVE SCENARIO 584 18.9.1 PRODUCT LAUNCHES 584 18.9.2 DEALS 585 18.9.3 EXPANSIONS 586 19 COMPANY PROFILES 587 19.1 KEY PLAYERS 587 19.1.1 THERMO FISHER SCIENTIFIC INC. 587 19.1.1.1 Business overview 587 19.1.1.2 Products & services offered 588 19.1.1.3 Recent developments 591 19.1.1.3.1 Product launches 591 19.1.1.3.2 Deals 593 19.1.1.3.3 Expansions 594 19.1.1.4 MnM view 595 19.1.1.4.1 Right to win 595 19.1.1.4.2 Strategic choices 595 19.1.1.4.3 Weaknesses & competitive threats 595 19.1.2 DANAHER CORPORATION 596 19.1.2.1 Business overview 596 19.1.2.2 Products & services offered 597 19.1.2.3 Recent developments 601 19.1.2.3.1 Product & service launches 601 19.1.2.3.2 Deals 601 19.1.2.4 MnM view 602 19.1.2.4.1 Right to win 602 19.1.2.4.2 Strategic choices 602 19.1.2.4.3 Weaknesses & competitive threats 602 19.1.3 MERCK KGAA 603 19.1.3.1 Business overview 603 19.1.3.2 Products & services offered 604 19.1.3.3 Recent developments 606 19.1.3.3.1 Deals 606 19.1.3.3.2 Expansions 607 19.1.3.3.3 Other developments 607 19.1.3.4 MnM view 607 19.1.3.4.1 Right to win 607 19.1.3.4.2 Strategic choices 608 19.1.3.4.3 Weaknesses & competitive threats 608 19.1.4 AGILENT TECHNOLOGIES, INC. 609 19.1.4.1 Business overview 609 19.1.4.2 Products & services offered 610 19.1.4.3 Recent developments 614 19.1.4.3.1 Product launches & upgrades 614 19.1.4.3.2 Deals 615 19.1.4.3.3 Expansions 616 19.1.4.3.4 Other developments 616 19.1.4.4 MnM view 617 19.1.4.4.1 Right to win 617 19.1.4.4.2 Strategic choices 617 19.1.4.4.3 Weaknesses & competitive threats 617   19.1.5 REVVITY, INC. 618 19.1.5.1 Business overview 618 19.1.5.2 Products & services offered 619 19.1.5.3 Recent developments 622 19.1.5.3.1 Product launches 622 19.1.5.3.2 Deals 623 19.1.5.4 MnM view 623 19.1.5.4.1 Right to win 623 19.1.5.4.2 Strategic choices 623 19.1.5.4.3 Weaknesses & competitive threats 623 19.1.6 TECAN GROUP LTD. 624 19.1.6.1 Business overview 624 19.1.6.2 Products & service offered 625 19.1.6.3 Recent developments 627 19.1.6.3.1 Product launches 627 19.1.6.3.2 Deals 627 19.1.7 BIO-RAD LABORATORIES, INC. 628 19.1.7.1 Business overview 628 19.1.7.2 Products & services offered 629 19.1.7.3 Recent developments 632 19.1.7.3.1 Product launches 632 19.1.8 CORNING INCORPORATED 633 19.1.8.1 Business overview 633 19.1.8.2 Products & services offered 634 19.1.9 METTLER-TOLEDO INTERNATIONAL INC. 636 19.1.9.1 Business overview 636 19.1.9.2 Products & services offered 637 19.1.10 LONZA GROUP 639 19.1.10.1 Business overview 639 19.1.10.2 Products & services offered 640 19.1.11 WATERS CORPORATION 641 19.1.11.1 Business overview 641 19.1.11.2 Products & services offered 642 19.1.11.3 Recent developments 644 19.1.11.3.1 Product launches 644 19.1.11.3.2 Deals 645 19.1.12 SARTORIUS AG 646 19.1.12.1 Business overview 646 19.1.12.2 Products & services offered 647 19.1.12.3 Recent developments 652 19.1.12.3.1 Product launches 652 19.1.12.3.2 Deals 652 19.1.12.3.3 Expansions 652 19.1.13 EPPENDORF SE 653 19.1.13.1 Business overview 653 19.1.13.2 Products & services offered 654 19.1.13.3 Recent developments 656 19.1.13.3.1 Product launches 656 19.1.13.3.2 Deals 656 19.1.13.3.3 Expansions 657 19.1.14 PORVAIR PLC 658 19.1.14.1 Business overview 658 19.1.14.2 Products & services offered 660 19.1.15 GREINER AG 661 19.1.15.1 Business overview 661 19.1.15.2 Products & services offered 662 19.1.16 CHARLES RIVER LABORATORIES 665 19.1.16.1 Business overview 665 19.1.16.2 products & services offered 667 19.1.16.3 Recent developments 667 19.1.16.3.1 Deals 667 19.1.17 EUROFINS SCIENTIFIC 668 19.1.17.1 Business overview 668 19.1.17.2 Products & services offered 669 19.1.17.3 Recent developments 671 19.1.17.3.1 Service launches 671 19.1.17.3.2 Deals 671 19.1.17.3.3 Expansions 671 19.1.18 HAMILTON COMPANY 672 19.1.18.1 Business overview 672 19.1.18.2 Products & services offered 672 19.1.18.3 Recent developments 673 19.1.18.3.1 Product launches 673 19.1.18.3.2 Deals 674 19.1.19 AURORA BIOMED INC. 675 19.1.19.1 Business overview 675 19.1.19.2 Products & services offered 675 19.1.20 GILSON INCORPORATED 676 19.1.20.1 Business overview 676 19.1.20.2 Products & services offered 676 19.1.21 BRAND GMBH + CO KG 682 19.1.21.1 Business overview 682 19.1.21.2 Products & services offered 682   19.2 OTHER PLAYERS 686 19.2.1 BMG LABTECH GMBH 686 19.2.2 DIANA BIOTECHNOLOGIES, A.S. 687 19.2.3 CREATIVE BIOLABS 687 19.2.4 HIGHRES BIOSOLUTIONS 689 19.2.5 BIOMAT SRL 690 19.2.6 AXXAM S.P.A. 691 19.2.7 SYGNATURE DISCOVERY LIMITED 692 19.2.8 CROWN BIOSCIENCE 694 20 RESEARCH METHODOLOGY 695 20.1 RESEARCH DATA 695 20.1.1 SECONDARY DATA 696 20.1.1.1 Key secondary sources 696 20.1.1.2 Key data from secondary research 696 20.1.2 PRIMARY DATA 697 20.1.2.1 Key primary participants 697 20.1.2.2 Breakdown of primary interviews 697 20.1.2.3 Key data from primary sources 698 20.2 MARKET SIZE ESTIMATION 698 20.2.1 GLOBAL HIGH-THROUGHPUT SCREENING MARKET ESTIMATION, 2025 698 20.2.1.1 Approach 1: Company revenue analysis-based estimation (bottom-up) 699 20.2.1.2 Approach 2: Primary research 700 20.2.1.2.1 Key industry insights 701 20.2.1.3 Approach 3: MnM repository analysis 701 20.2.2 SEGMENTAL MARKET SIZE ESTIMATION, 2025 702 20.3 MARKET GROWTH RATE PROJECTIONS 704 20.4 DATA TRIANGULATION 706 20.5 RESEARCH ASSUMPTIONS 707 20.6 RESEARCH LIMITATIONS AND RISK ASSESSMENT 708 21 APPENDIX 709 21.1 DISCUSSION GUIDE 709 21.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 715 21.3 CUSTOMIZATION OPTIONS 717 21.4 RELATED REPORTS 717 21.5 AUTHOR DETAILS 718
圖表清單 List of Tables & Figures
TABLE 1 HIGH-THROUGHPUT SCREENING (HTS) MARKET: INCLUSIONS & EXCLUSIONS 62 TABLE 2 HIGH-THROUGHPUT SCREENING (HTS) MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS 77 TABLE 3 HIGH-THROUGHPUT SCREENING (HTS) MARKET: IMPACT OF PORTER’S FIVE FORCES 87 TABLE 4 HIGH-THROUGHPUT SCREENING (HTS) MARKET: ROLE IN ECOSYSTEM 92 TABLE 5 AVERAGE SELLING PRICE TREND OF HTS PRODUCTS, BY KEY PLAYER, 2023–2025 (USD) 93 TABLE 6 AVERAGE SELLING PRICE TREND OF HTS PRODUCTS, BY REGION, 2023–2025 (USD) 95 TABLE 7 IMPORT VALUE FOR HS CODE 902730, 2021–2025 (USD THOUSAND) 96 TABLE 8 IMPORT VOLUME FOR HS CODE 902730, 2021–2025 (TONS) 97 TABLE 9 IMPORT VALUE FOR HS CODE 902781, 2022–2025 (USD THOUSAND) 98 TABLE 10 IMPORT VOLUME FOR HS CODE 902781, 2022–2025 (UNITS) 99 TABLE 11 EXPORT VALUE FOR HS CODE 902730, BY COUNTRY, 2021–2025 (USD THOUSAND) 99 TABLE 12 EXPORT VOLUME FOR HS CODE 902730, BY COUNTRY, 2021–2025 (TONS) 100 TABLE 13 EXPORT VALUE FOR HS CODE 902781, 2022–2025 (USD THOUSAND) 101 TABLE 14 EXPORT VOLUME FOR HS CODE 902781, 2022–2025 (UNITS) 101 TABLE 15 HIGH-THROUGHPUT SCREENING (HTS) MARKET: KEY CONFERENCES & EVENTS, 2026–2027 102 TABLE 16 US-ADJUSTED RECIPROCAL TARIFF RATES 105 TABLE 17 HIGH-THROUGHPUT SCREENING (HTS) MARKET: INDICATIVE LIST OF PATENTS, 2026 114 TABLE 18 CASE STUDIES OF AI IMPLEMENTATION IN HIGH-THROUGHPUT SCREENING (HTS) MARKET 118 TABLE 19 CLIENT’S READINESS TO ADOPT GENERATIVE AI IN HIGH-THROUGHPUT SCREENING 119 TABLE 20 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 120 TABLE 21 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 120 TABLE 22 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 121 TABLE 23 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 122 TABLE 24 US FOOD AND DRUG ADMINISTRATION: MEDICAL DEVICE CLASSIFICATION 123 TABLE 25 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 123 TABLE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING (%) 125 TABLE 27 KEY BUYING CRITERIA, BY END USER 126 TABLE 28 HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION) 130 TABLE 29 HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY REGION, 2024–2031 (USD MILLION) 131 TABLE 30 NORTH AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 131 TABLE 31 EUROPE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 132 TABLE 32 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 132 TABLE 33 LATIN AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 133 TABLE 34 MIDDLE EAST: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY REGION, 2024–2031 (USD MILLION) 133 TABLE 35 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 133 TABLE 36 HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 134 TABLE 37 NORTH AMERICA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 135 TABLE 38 EUROPE: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 135 TABLE 39 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 136 TABLE 40 LATIN AMERICA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 136 TABLE 41 MIDDLE EAST: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 136 TABLE 42 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 137 TABLE 43 HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 139 TABLE 44 HTS REAGENTS, KITS, AND CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION) 140 TABLE 45 NORTH AMERICA: HTS REAGENTS, KITS, AND CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 140 TABLE 46 EUROPE: HTS REAGENTS, KITS, AND CONSUMABLES MARKET, 2024–2031 (USD MILLION) 141 TABLE 47 ASIA PACIFIC: HTS REAGENTS, KITS, AND CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 141 TABLE 48 LATIN AMERICA: HTS REAGENTS, KITS, AND CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 142 TABLE 49 MIDDLE EAST: HTS REAGENTS, KITS, AND CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION) 142 TABLE 50 GCC COUNTRIES: HTS REAGENTS, KITS, AND CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 142 TABLE 51 HTS REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 143 TABLE 52 SCREENING ASSAY KITS MARKET, BY REGION, 2024–2031 (USD MILLION) 143 TABLE 53 NORTH AMERICA: SCREENING ASSAY KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 144 TABLE 54 EUROPE: SCREENING ASSAY KITS MARKET, 2024–2031 (USD MILLION) 144 TABLE 55 ASIA PACIFIC: SCREENING ASSAY KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 145 TABLE 56 LATIN AMERICA: SCREENING ASSAY KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 145 TABLE 57 MIDDLE EAST: SCREENING ASSAY KITS MARKET, BY REGION, 2024–2031 (USD MILLION) 145 TABLE 58 GCC COUNTRIES: SCREENING ASSAY KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 146 TABLE 59 SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 146 TABLE 60 CELL-BASED ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION) 147 TABLE 61 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 147 TABLE 62 EUROPE: CELL-BASED ASSAYS MARKET, 2024–2031 (USD MILLION) 147 TABLE 63 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 148 TABLE 64 LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 148 TABLE 65 MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION) 148 TABLE 66 GCC COUNTRIES: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 149 TABLE 67 CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 149 TABLE 68 CELL VIABILITY ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION) 150 TABLE 69 NORTH AMERICA: CELL VIABILITY ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 150 TABLE 70 EUROPE: CELL VIABILITY ASSAYS MARKET, 2024–2031 (USD MILLION) 150 TABLE 71 ASIA PACIFIC: CELL VIABILITY ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 151 TABLE 72 LATIN AMERICA: CELL VIABILITY ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 151 TABLE 73 MIDDLE EAST: CELL VIABILITY ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION) 151 TABLE 74 GCC COUNTRIES: CELL VIABILITY ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 152 TABLE 75 CYTOTOXICITY ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION) 152 TABLE 76 NORTH AMERICA: CYTOTOXICITY ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 153 TABLE 77 EUROPE: CYTOTOXICITY ASSAYS MARKET, 2024–2031 (USD MILLION) 153 TABLE 78 ASIA PACIFIC: CYTOTOXICITY ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 153 TABLE 79 LATIN AMERICA: CYTOTOXICITY ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 154 TABLE 80 MIDDLE EAST: CYTOTOXICITY ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION) 154 TABLE 81 GCC COUNTRIES: CYTOTOXICITY ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 154 TABLE 82 REPORTER GENE ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION) 155 TABLE 83 NORTH AMERICA: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 155 TABLE 84 EUROPE: REPORTER GENE ASSAYS MARKET, 2024–2031 (USD MILLION) 156 TABLE 85 ASIA PACIFIC: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 156 TABLE 86 LATIN AMERICA: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 157 TABLE 87 MIDDLE EAST: REPORTER GENE ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION) 157 TABLE 88 GCC COUNTRIES: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 157 TABLE 89 OTHER CELL-BASED ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION) 158 TABLE 90 NORTH AMERICA: OTHER CELL-BASED ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 158 TABLE 91 EUROPE: OTHER CELL-BASED ASSAYS MARKET, 2024–2031 (USD MILLION) 159 TABLE 92 ASIA PACIFIC: OTHER CELL-BASED ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 159 TABLE 93 LATIN AMERICA: OTHER CELL-BASED ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 160 TABLE 94 MIDDLE EAST: OTHER CELL-BASED ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION) 160 TABLE 95 GCC COUNTRIES: OTHER CELL-BASED ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 160 TABLE 96 BIOCHEMICAL ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION) 161 TABLE 97 NORTH AMERICA: BIOCHEMICAL ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 161 TABLE 98 EUROPE: BIOCHEMICAL ASSAYS MARKET, 2024–2031 (USD MILLION) 162 TABLE 99 ASIA PACIFIC: BIOCHEMICAL ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 162 TABLE 100 LATIN AMERICA: BIOCHEMICAL ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 163 TABLE 101 MIDDLE EAST: BIOCHEMICAL ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION) 163 TABLE 102 GCC COUNTRIES: BIOCHEMICAL ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 163 TABLE 103 BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 164 TABLE 104 ENZYME ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION) 164 TABLE 105 NORTH AMERICA: ENZYME ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 165 TABLE 106 EUROPE: ENZYME ASSAYS MARKET, 2024–2031 (USD MILLION) 165 TABLE 107 ASIA PACIFIC: ENZYME ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 165 TABLE 108 LATIN AMERICA: ENZYME ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 166 TABLE 109 MIDDLE EAST: ENZYME ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION) 166 TABLE 110 GCC COUNTRIES: ENZYME ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 166 TABLE 111 KINASE ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION) 167 TABLE 112 NORTH AMERICA: KINASE ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 167 TABLE 113 EUROPE: KINASE ASSAYS MARKET, 2024–2031 (USD MILLION) 168 TABLE 114 ASIA PACIFIC: KINASE ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 168 TABLE 115 LATIN AMERICA: KINASE ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 168 TABLE 116 MIDDLE EAST: KINASE ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION) 169 TABLE 117 GCC COUNTRIES: KINASE ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 169 TABLE 118 BINDING ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION) 170 TABLE 119 NORTH AMERICA: BINDING ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 170 TABLE 120 EUROPE: BINDING ASSAYS MARKET, 2024–2031 (USD MILLION) 170 TABLE 121 ASIA PACIFIC: BINDING ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 171 TABLE 122 LATIN AMERICA: BINDING ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 171 TABLE 123 MIDDLE EAST: BINDING ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION) 171 TABLE 124 GCC COUNTRIES: BINDING ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 172 TABLE 125 OTHER BIOCHEMICAL ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION) 172 TABLE 126 NORTH AMERICA: OTHER BIOCHEMICAL ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 173 TABLE 127 EUROPE: OTHER BIOCHEMICAL ASSAYS MARKET, 2024–2031 (USD MILLION) 173 TABLE 128 ASIA PACIFIC: OTHER BIOCHEMICAL ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 174 TABLE 129 LATIN AMERICA: OTHER BIOCHEMICAL ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 174 TABLE 130 MIDDLE EAST: OTHER BIOCHEMICAL ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION) 174 TABLE 131 GCC COUNTRIES: OTHER BIOCHEMICAL ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 175 TABLE 132 OTHER ASSAYS & KITS MARKET, BY REGION, 2024–2031 (USD MILLION) 175 TABLE 133 NORTH AMERICA: OTHER ASSAYS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 176 TABLE 134 EUROPE: OTHER ASSAYS & KITS MARKET, 2024–2031 (USD MILLION) 176 TABLE 135 ASIA PACIFIC: OTHER ASSAYS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 176 TABLE 136 LATIN AMERICA: OTHER ASSAYS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 177 TABLE 137 MIDDLE EAST: OTHER ASSAYS & KITS MARKET, BY REGION, 2024–2031 (USD MILLION) 177 TABLE 138 GCC COUNTRIES: OTHER ASSAYS & KITS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 177 TABLE 139 BIOLOGICAL & CELL CULTURE REAGENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 178 TABLE 140 NORTH AMERICA: BIOLOGICAL & CELL CULTURE REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 178 TABLE 141 EUROPE: BIOLOGICAL & CELL CULTURE REAGENTS MARKET, 2024–2031 (USD MILLION) 179 TABLE 142 ASIA PACIFIC: BIOLOGICAL & CELL CULTURE REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 179 TABLE 143 LATIN AMERICA: BIOLOGICAL & CELL CULTURE REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 180 TABLE 144 MIDDLE EAST: BIOLOGICAL & CELL CULTURE REAGENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 180 TABLE 145 GCC COUNTRIES: BIOLOGICAL & CELL CULTURE REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 180 TABLE 146 COMPOUND LIBRARIES MARKET, BY REGION, 2024–2031 (USD MILLION) 181 TABLE 147 NORTH AMERICA: COMPOUND LIBRARIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 181 TABLE 148 EUROPE: COMPOUND LIBRARIES MARKET, 2024–2031 (USD MILLION) 182 TABLE 149 ASIA PACIFIC: COMPOUND LIBRARIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 182 TABLE 150 LATIN AMERICA: COMPOUND LIBRARIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 183 TABLE 151 MIDDLE EAST: COMPOUND LIBRARIES MARKET, BY REGION, 2024–2031 (USD MILLION) 183 TABLE 152 GCC COUNTRIES: COMPOUND LIBRARIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 183 TABLE 153 DETECTION REAGENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 184 TABLE 154 NORTH AMERICA: DETECTION REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 184 TABLE 155 EUROPE: DETECTION REAGENTS MARKET, 2024–2031 (USD MILLION) 185 TABLE 156 ASIA PACIFIC: DETECTION REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 185 TABLE 157 LATIN AMERICA: DETECTION REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 185 TABLE 158 MIDDLE EAST: DETECTION REAGENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 186 TABLE 159 GCC COUNTRIES: DETECTION REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 186 TABLE 160 3D CELL CULTURE PRODUCTS MARKET, BY REGION, 2024–2031 (USD MILLION) 187 TABLE 161 NORTH AMERICA: 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 187 TABLE 162 EUROPE: 3D CELL CULTURE PRODUCTS MARKET, 2024–2031 (USD MILLION) 187 TABLE 163 ASIA PACIFIC: 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 188 TABLE 164 LATIN AMERICA: 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 188 TABLE 165 MIDDLE EAST: 3D CELL CULTURE PRODUCTS MARKET, BY REGION, 2024–2031 (USD MILLION) 188 TABLE 166 GCC COUNTRIES: 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 189 TABLE 167 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 189 TABLE 168 SCAFFOLD-BASED 3D CELL CULTURE PRODUCTS MARKET, BY REGION, 2024–2031 (USD MILLION) 190 TABLE 169 NORTH AMERICA: SCAFFOLD-BASED 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 190 TABLE 170 EUROPE: SCAFFOLD-BASED 3D CELL CULTURE PRODUCTS MARKET, 2024–2031 (USD MILLION) 191 TABLE 171 ASIA PACIFIC: SCAFFOLD-BASED 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 191 TABLE 172 LATIN AMERICA: SCAFFOLD-BASED 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 192 TABLE 173 MIDDLE EAST: SCAFFOLD-BASED 3D CELL CULTURE PRODUCTS MARKET, BY REGION, 2024–2031 (USD MILLION) 192 TABLE 174 GCC COUNTRIES: SCAFFOLD-BASED 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 192 TABLE 175 SCAFFOLD-FREE 3D CELL CULTURE PRODUCTS MARKET, BY REGION, 2024–2031 (USD MILLION) 193 TABLE 176 NORTH AMERICA: SCAFFOLD-FREE 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 193 TABLE 177 EUROPE: SCAFFOLD-FREE 3D CELL CULTURE PRODUCTS MARKET, 2024–2031 (USD MILLION) 194 TABLE 178 ASIA PACIFIC: SCAFFOLD-FREE 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 194 TABLE 179 LATIN AMERICA: SCAFFOLD-FREE 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 195 TABLE 180 MIDDLE EAST: SCAFFOLD-FREE 3D CELL CULTURE PRODUCTS MARKET, BY REGION, 2024–2031 (USD MILLION) 195 TABLE 181 GCC COUNTRIES: SCAFFOLD-FREE 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 195 TABLE 182 OTHER 3D CELL CULTURE PRODUCTS MARKET, BY REGION, 2024–2031 (USD MILLION) 196 TABLE 183 NORTH AMERICA: OTHER 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 196 TABLE 184 EUROPE: OTHER 3D CELL CULTURE PRODUCTS MARKET, 2024–2031 (USD MILLION) 197 TABLE 185 ASIA PACIFIC: OTHER 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 197 TABLE 186 LATIN AMERICA: OTHER 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 198 TABLE 187 MIDDLE EAST: OTHER 3D CELL CULTURE PRODUCTS MARKET, BY REGION, 2024–2031 (USD MILLION) 198 TABLE 188 GCC COUNTRIES: OTHER 3D CELL CULTURE PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 198 TABLE 189 OTHER HTS CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION) 199 TABLE 190 NORTH AMERICA: OTHER HTS CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 199 TABLE 191 EUROPE: OTHER HTS CONSUMABLES MARKET, 2024–2031 (USD MILLION) 200 TABLE 192 ASIA PACIFIC: OTHER HTS CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 200 TABLE 193 LATIN AMERICA: OTHER HTS CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 201 TABLE 194 MIDDLE EAST: OTHER HTS CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION) 201 TABLE 195 GCC COUNTRIES: OTHER HTS CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 201 TABLE 196 HTS INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 202 TABLE 197 NORTH AMERICA: HTS INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 203 TABLE 198 EUROPE: HTS INSTRUMENTS MARKET, 2024–2031 (USD MILLION) 203 TABLE 199 ASIA PACIFIC: HTS INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 203 TABLE 200 LATIN AMERICA: HTS INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 204 TABLE 201 MIDDLE EAST: HTS INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 204 TABLE 202 GCC COUNTRIES: HTS INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 204 TABLE 203 HTS INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 205 TABLE 204 DETECTION & IMAGING SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 206 TABLE 205 NORTH AMERICA: DETECTION & IMAGING SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 206 TABLE 206 EUROPE: DETECTION & IMAGING SYSTEMS MARKET, 2024–2031 (USD MILLION) 206 TABLE 207 ASIA PACIFIC: DETECTION & IMAGING SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 207 TABLE 208 LATIN AMERICA: DETECTION & IMAGING SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 207 TABLE 209 MIDDLE EAST: DETECTION & IMAGING SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 207 TABLE 210 GCC COUNTRIES: DETECTION & IMAGING SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 208 TABLE 211 DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 208 TABLE 212 MICROPLATE READERS MARKET, BY REGION, 2024–2031 (USD MILLION) 209 TABLE 213 NORTH AMERICA: MICROPLATE READERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 209 TABLE 214 EUROPE: MICROPLATE READERS MARKET, 2024–2031 (USD MILLION) 210 TABLE 215 ASIA PACIFIC: MICROPLATE READERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 210 TABLE 216 LATIN AMERICA: MICROPLATE READERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 211 TABLE 217 MIDDLE EAST: MICROPLATE READERS MARKET, BY REGION, 2024–2031 (USD MILLION) 211 TABLE 218 GCC COUNTRIES: MICROPLATE READERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 211 TABLE 219 HIGH-CONTENT SCREENING & IMAGING SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 212 TABLE 220 NORTH AMERICA: HIGH-CONTENT SCREENING & IMAGING SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 213 TABLE 221 EUROPE: HIGH-CONTENT SCREENING & IMAGING SYSTEMS MARKET, 2024–2031 (USD MILLION) 213 TABLE 222 ASIA PACIFIC: HIGH-CONTENT SCREENING & IMAGING SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 214 TABLE 223 LATIN AMERICA: HIGH-CONTENT SCREENING & IMAGING SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 214 TABLE 224 MIDDLE EAST: HIGH-CONTENT SCREENING & IMAGING SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 214 TABLE 225 GCC COUNTRIES: HIGH-CONTENT SCREENING & IMAGING SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 215 TABLE 226 CELL ANALYSIS SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 215 TABLE 227 NORTH AMERICA: CELL ANALYSIS SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 216 TABLE 228 EUROPE: CELL ANALYSIS SYSTEMS MARKET, 2024–2031 (USD MILLION) 216 TABLE 229 ASIA PACIFIC: CELL ANALYSIS SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 217 TABLE 230 LATIN AMERICA: CELL ANALYSIS SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 217 TABLE 231 MIDDLE EAST: CELL ANALYSIS SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 217 TABLE 232 GCC COUNTRIES: CELL ANALYSIS SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 218 TABLE 233 LABEL-FREE DETECTION SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 219 TABLE 234 NORTH AMERICA: LABEL-FREE DETECTION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 219 TABLE 235 EUROPE: LABEL-FREE DETECTION SYSTEMS MARKET, 2024–2031 (USD MILLION) 219 TABLE 236 ASIA PACIFIC: LABEL-FREE DETECTION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 220 TABLE 237 LATIN AMERICA: LABEL-FREE DETECTION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 220 TABLE 238 MIDDLE EAST: LABEL-FREE DETECTION SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 220 TABLE 239 GCC COUNTRIES: LABEL-FREE DETECTION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 221 TABLE 240 MICROFLUIDIC & MINIATURIZED SCREENING SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 222 TABLE 241 NORTH AMERICA: MICROFLUIDIC & MINIATURIZED SCREENING SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 222 TABLE 242 EUROPE: MICROFLUIDIC & MINIATURIZED SCREENING SYSTEMS MARKET, 2024–2031 (USD MILLION) 223 TABLE 243 ASIA PACIFIC: MICROFLUIDIC & MINIATURIZED SCREENING SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 223 TABLE 244 LATIN AMERICA: MICROFLUIDIC & MINIATURIZED SCREENING SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 224 TABLE 245 MIDDLE EAST: MICROFLUIDIC & MINIATURIZED SCREENING SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 224 TABLE 246 GCC COUNTRIES: MICROFLUIDIC & MINIATURIZED SCREENING SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 224 TABLE 247 LIQUID HANDLING & AUTOMATION SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 225 TABLE 248 NORTH AMERICA: LIQUID HANDLING & AUTOMATION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 226 TABLE 249 EUROPE: LIQUID HANDLING & AUTOMATION SYSTEMS MARKET, 2024–2031 (USD MILLION) 226 TABLE 250 ASIA PACIFIC: LIQUID HANDLING & AUTOMATION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 227 TABLE 251 LATIN AMERICA: LIQUID HANDLING & AUTOMATION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 227 TABLE 252 MIDDLE EAST: LIQUID HANDLING & AUTOMATION SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 227 TABLE 253 GCC COUNTRIES: LIQUID HANDLING & AUTOMATION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 228 TABLE 254 ROBOTIC HTS PLATFORMS & AUTOMATED WORKFLOW SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 228 TABLE 255 NORTH AMERICA: ROBOTIC HTS PLATFORMS & AUTOMATED WORKFLOW SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 229 TABLE 256 EUROPE: ROBOTIC HTS PLATFORMS & AUTOMATED WORKFLOW SYSTEMS MARKET, 2024–2031 (USD MILLION) 229 TABLE 257 ASIA PACIFIC: ROBOTIC HTS PLATFORMS & AUTOMATED WORKFLOW SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 230 TABLE 258 LATIN AMERICA: ROBOTIC HTS PLATFORMS & AUTOMATED WORKFLOW SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 230 TABLE 259 MIDDLE EAST: ROBOTIC HTS PLATFORMS & AUTOMATED WORKFLOW SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 230 TABLE 260 GCC COUNTRIES: ROBOTIC HTS PLATFORMS & AUTOMATED WORKFLOW SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 231 TABLE 261 OTHER HTS INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 232 TABLE 262 NORTH AMERICA: OTHER HTS INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 232 TABLE 263 EUROPE: OTHER HTS INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 232 TABLE 264 ASIA PACIFIC: OTHER HTS INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 233 TABLE 265 LATIN AMERICA: OTHER HTS INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 233 TABLE 266 MIDDLE EAST: OTHER HTS INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 233 TABLE 267 GCC COUNTRIES: OTHER HTS INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 234 TABLE 268 HTS SOFTWARE & INFORMATICS MARKET, BY REGION, 2024–2031 (USD MILLION) 235 TABLE 269 NORTH AMERICA: HTS SOFTWARE & INFORMATICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 235 TABLE 270 EUROPE: HTS SOFTWARE & INFORMATICS MARKET, 2024–2031 (USD MILLION) 236 TABLE 271 ASIA PACIFIC: HTS SOFTWARE & INFORMATICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 236 TABLE 272 LATIN AMERICA: HTS SOFTWARE & INFORMATICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 237 TABLE 273 MIDDLE EAST: HTS SOFTWARE & INFORMATICS MARKET, BY REGION, 2024–2031 (USD MILLION) 237 TABLE 274 GCC COUNTRIES: HTS SOFTWARE & INFORMATICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 237 TABLE 275 HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 239 TABLE 276 CELL-BASED SCREENING TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION) 240 TABLE 277 NORTH AMERICA: CELL-BASED SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 241 TABLE 278 EUROPE: CELL-BASED SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 241 TABLE 279 ASIA PACIFIC: CELL-BASED SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 242 TABLE 280 LATIN AMERICA: CELL-BASED SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 242 TABLE 281 MIDDLE EAST: CELL-BASED SCREENING TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION) 242 TABLE 282 GCC COUNTRIES: CELL-BASED SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 243 TABLE 283 ULTRA-HIGH-THROUGHPUT & AUTOMATION TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION) 244 TABLE 284 NORTH AMERICA: ULTRA-HIGH-THROUGHPUT & AUTOMATION TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 244 TABLE 285 EUROPE: ULTRA-HIGH-THROUGHPUT & AUTOMATION TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 245 TABLE 286 ASIA PACIFIC: ULTRA-HIGH-THROUGHPUT & AUTOMATION TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 245 TABLE 287 LATIN AMERICA: ULTRA-HIGH-THROUGHPUT & AUTOMATION TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 246 TABLE 288 MIDDLE EAST: ULTRA-HIGH-THROUGHPUT & AUTOMATION TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION) 246 TABLE 289 GCC COUNTRIES: ULTRA-HIGH-THROUGHPUT & AUTOMATION TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 246 TABLE 290 HIGH-CONTENT SCREENING (HCS) TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION) 247 TABLE 291 NORTH AMERICA: HIGH-CONTENT SCREENING (HCS) TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 248 TABLE 292 EUROPE: HIGH-CONTENT SCREENING (HCS) TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 248 TABLE 293 ASIA PACIFIC: HIGH-CONTENT SCREENING (HCS) TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 249 TABLE 294 LATIN AMERICA: HIGH-CONTENT SCREENING (HCS) TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 249 TABLE 295 MIDDLE EAST: HIGH-CONTENT SCREENING (HCS) TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION) 249 TABLE 296 GCC COUNTRIES: HIGH-CONTENT SCREENING (HCS) TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 250 TABLE 297 BIOCHEMICAL SCREENING TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION) 251 TABLE 298 NORTH AMERICA: BIOCHEMICAL SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 251 TABLE 299 EUROPE: BIOCHEMICAL SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 252 TABLE 300 ASIA PACIFIC: BIOCHEMICAL SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 252 TABLE 301 LATIN AMERICA: BIOCHEMICAL SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 253 TABLE 302 MIDDLE EAST: BIOCHEMICAL SCREENING TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION) 253 TABLE 303 GCC COUNTRIES: BIOCHEMICAL SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 253 TABLE 304 3D CELL CULTURE & ADVANCED CELLULAR MODEL TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION) 254 TABLE 305 NORTH AMERICA: 3D CELL CULTURE & ADVANCED CELLULAR MODEL TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 255 TABLE 306 EUROPE: 3D CELL CULTURE & ADVANCED CELLULAR MODEL TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 255 TABLE 307 ASIA PACIFIC: 3D CELL CULTURE & ADVANCED CELLULAR MODEL TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 256 TABLE 308 LATIN AMERICA: 3D CELL CULTURE & ADVANCED CELLULAR MODEL TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 256 TABLE 309 MIDDLE EAST: 3D CELL CULTURE & ADVANCED CELLULAR MODEL TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION) 256 TABLE 310 GCC COUNTRIES: 3D CELL CULTURE & ADVANCED CELLULAR MODEL TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 257 TABLE 311 LABEL-FREE SCREENING TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION) 258 TABLE 312 NORTH AMERICA: LABEL-FREE SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 258 TABLE 313 EUROPE: LABEL-FREE SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 259 TABLE 314 ASIA PACIFIC: LABEL-FREE SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 259 TABLE 315 LATIN AMERICA: LABEL-FREE SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 260 TABLE 316 MIDDLE EAST: LABEL-FREE SCREENING TECHNOLOGIES MARKE T, BY REGION, 2024–2031 (USD MILLION) 260 TABLE 317 GCC COUNTRIES: LABEL-FREE SCREENING TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 260 TABLE 318 OTHER HTS TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION) 261 TABLE 319 NORTH AMERICA: OTHER HTS TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 261 TABLE 320 EUROPE: OTHER HTS TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 262 TABLE 321 ASIA PACIFIC: OTHER HTS TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 262 TABLE 322 LATIN AMERICA: OTHER HTS TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 263 TABLE 323 MIDDLE EAST: OTHER HTS TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION) 263 TABLE 324 GCC COUNTRIES: OTHER HTS TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 263 TABLE 325 HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 265 TABLE 326 HTS PRODUCTS MARKET FOR PRIMARY SCREENING, BY REGION, 2024–2031 (USD MILLION) 266 TABLE 327 NORTH AMERICA: HTS PRODUCTS MARKET FOR PRIMARY SCREENING, BY COUNTRY, 2024–2031 (USD MILLION) 266 TABLE 328 EUROPE: HTS PRODUCTS MARKET FOR PRIMARY SCREENING, BY COUNTRY, 2024–2031 (USD MILLION) 267 TABLE 329 ASIA PACIFIC: HTS PRODUCTS MARKET FOR PRIMARY SCREENING, BY COUNTRY, 2024–2031 (USD MILLION) 267 TABLE 330 LATIN AMERICA: HTS PRODUCTS MARKET FOR PRIMARY SCREENING, BY COUNTRY, 2024–2031 (USD MILLION) 268 TABLE 331 MIDDLE EAST: HTS PRODUCTS MARKET FOR PRIMARY SCREENING, BY REGION, 2024–2031 (USD MILLION) 268 TABLE 332 GCC COUNTRIES: HTS PRODUCTS MARKET FOR PRIMARY SCREENING, BY COUNTRY, 2024–2031 (USD MILLION) 268 TABLE 333 HTS PRODUCTS MARKET FOR ASSAY DEVELOPMENT & OPTIMIZATION, BY REGION, 2024–2031 (USD MILLION) 269 TABLE 334 NORTH AMERICA: HTS PRODUCTS MARKET FOR ASSAY DEVELOPMENT & OPTIMIZATION, BY COUNTRY, 2024–2031 (USD MILLION) 270 TABLE 335 EUROPE: HTS PRODUCTS MARKET FOR ASSAY DEVELOPMENT & OPTIMIZATION, BY COUNTRY, 2024–2031 (USD MILLION) 270 TABLE 336 ASIA PACIFIC: HTS PRODUCTS MARKET FOR ASSAY DEVELOPMENT & OPTIMIZATION, BY COUNTRY, 2024–2031 (USD MILLION) 271 TABLE 337 LATIN AMERICA: HTS PRODUCTS MARKET FOR ASSAY DEVELOPMENT & OPTIMIZATION, BY COUNTRY, 2024–2031 (USD MILLION) 271 TABLE 338 MIDDLE EAST: HTS PRODUCTS MARKET FOR ASSAY DEVELOPMENT & OPTIMIZATION, BY REGION, 2024–2031 (USD MILLION) 271 TABLE 339 GCC COUNTRIES: HTS PRODUCTS MARKET FOR ASSAY DEVELOPMENT & OPTIMIZATION, BY COUNTRY, 2024–2031 (USD MILLION) 272 TABLE 340 HTS PRODUCTS MARKET FOR HIT CONFIRMATION/SECONDARY SCREENING, BY REGION, 2024–2031 (USD MILLION) 273 TABLE 341 NORTH AMERICA: HTS PRODUCTS MARKET FOR HIT CONFIRMATION/SECONDARY SCREENING, BY COUNTRY, 2024–2031 (USD MILLION) 273 TABLE 342 EUROPE: HTS PRODUCTS MARKET FOR HIT CONFIRMATION/SECONDARY SCREENING, BY COUNTRY, 2024–2031 (USD MILLION) 274 TABLE 343 ASIA PACIFIC: HTS PRODUCTS MARKET FOR HIT CONFIRMATION/SECONDARY SCREENING, BY COUNTRY, 2024–2031 (USD MILLION) 274 TABLE 344 LATIN AMERICA: HTS PRODUCTS MARKET FOR HIT CONFIRMATION/SECONDARY SCREENING, BY COUNTRY, 2024–2031 (USD MILLION) 275 TABLE 345 MIDDLE EAST: HTS PRODUCTS MARKET FOR HIT CONFIRMATION/SECONDARY SCREENING, BY REGION, 2024–2031 (USD MILLION) 275 TABLE 346 GCC COUNTRIES: HTS PRODUCTS MARKET FOR HIT CONFIRMATION/SECONDARY SCREENING, BY COUNTRY, 2024–2031 (USD MILLION) 275 TABLE 347 HTS PRODUCTS MARKET FOR DATA ANALYSIS & HIT IDENTIFICATION, BY REGION, 2024–2031 (USD MILLION) 276 TABLE 348 NORTH AMERICA: HTS PRODUCTS MARKET FOR DATA ANALYSIS & HIT IDENTIFICATION, BY COUNTRY, 2024–2031 (USD MILLION) 277 TABLE 349 EUROPE: HTS PRODUCTS MARKET FOR DATA ANALYSIS & HIT IDENTIFICATION, BY COUNTRY, 2024–2031 (USD MILLION) 277 TABLE 350 ASIA PACIFIC: HTS PRODUCTS MARKET FOR DATA ANALYSIS & HIT IDENTIFICATION, BY COUNTRY, 2024–2031 (USD MILLION) 278 TABLE 351 LATIN AMERICA: HTS PRODUCTS MARKET FOR DATA ANALYSIS & HIT IDENTIFICATION, BY COUNTRY, 2024–2031 (USD MILLION) 278 TABLE 352 MIDDLE EAST: HTS PRODUCTS MARKET FOR DATA ANALYSIS & HIT IDENTIFICATION, BY REGION, 2024–2031 (USD MILLION) 278 TABLE 353 GCC COUNTRIES: HTS PRODUCTS MARKET FOR DATA ANALYSIS & HIT IDENTIFICATION, BY COUNTRY, 2024–2031 (USD MILLION) 279 TABLE 354 HTS PRODUCTS MARKET FOR COMPOUND LIBRARY PREPARATION, BY REGION, 2024–2031 (USD MILLION) 279 TABLE 355 NORTH AMERICA: HTS PRODUCTS MARKET FOR COMPOUND LIBRARY PREPARATION, BY COUNTRY, 2024–2031 (USD MILLION) 280 TABLE 356 EUROPE: HTS PRODUCTS MARKET FOR COMPOUND LIBRARY PREPARATION, BY COUNTRY, 2024–2031 (USD MILLION) 280 TABLE 357 ASIA PACIFIC: HTS PRODUCTS MARKET FOR COMPOUND LIBRARY PREPARATION, BY COUNTRY, 2024–2031 (USD MILLION) 281 TABLE 358 LATIN AMERICA: HTS PRODUCTS MARKET FOR COMPOUND LIBRARY PREPARATION, BY COUNTRY, 2024–2031 (USD MILLION) 281 TABLE 359 MIDDLE EAST: HTS PRODUCTS MARKET FOR COMPOUND LIBRARY PREPARATION, BY REGION, 2024–2031 (USD MILLION) 281 TABLE 360 GCC COUNTRIES: HTS PRODUCTS MARKET FOR COMPOUND LIBRARY PREPARATION, BY COUNTRY, 2024–2031 (USD MILLION) 282 TABLE 361 HTS PRODUCTS MARKET FOR HIT VALIDATION & CHARACTERIZATION, BY REGION, 2024–2031 (USD MILLION) 283 TABLE 362 NORTH AMERICA: HTS PRODUCTS MARKET FOR HIT VALIDATION & CHARACTERIZATION, BY COUNTRY, 2024–2031 (USD MILLION) 283 TABLE 363 EUROPE: HTS PRODUCTS MARKET FOR HIT VALIDATION & CHARACTERIZATION, BY COUNTRY, 2024–2031 (USD MILLION) 284 TABLE 364 ASIA PACIFIC: HTS PRODUCTS MARKET FOR HIT VALIDATION & CHARACTERIZATION, BY COUNTRY, 2024–2031 (USD MILLION) 284 TABLE 365 LATIN AMERICA: HTS PRODUCTS MARKET FOR HIT VALIDATION & CHARACTERIZATION, BY COUNTRY, 2024–2031 (USD MILLION) 285 TABLE 366 MIDDLE EAST: HTS PRODUCTS MARKET FOR HIT VALIDATION & CHARACTERIZATION, BY REGION, 2024–2031 (USD MILLION) 285 TABLE 367 GCC COUNTRIES: HTS PRODUCTS MARKET FOR HIT VALIDATION & CHARACTERIZATION, BY COUNTRY, 2024–2031 (USD MILLION) 285 TABLE 368 HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 287 TABLE 369 HTS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION) 288 TABLE 370 NORTH AMERICA: HTS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 288 TABLE 371 EUROPE: HTS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 289 TABLE 372 ASIA PACIFIC: HTS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 289 TABLE 373 LATIN AMERICA: HTS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 290 TABLE 374 MIDDLE EAST: HTS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION) 290 TABLE 375 GCC COUNTRIES: HTS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 290 TABLE 376 HTS PRODUCTS MARKET FOR CROS & CDMOS, BY REGION, 2024–2031 (USD MILLION) 291 TABLE 377 NORTH AMERICA: HTS PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024–2031 (USD MILLION) 292 TABLE 378 EUROPE: HTS PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024–2031 (USD MILLION) 292 TABLE 379 ASIA PACIFIC: HTS PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024–2031 (USD MILLION) 293 TABLE 380 LATIN AMERICA: HTS PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024–2031 (USD MILLION) 293 TABLE 381 MIDDLE EAST: HTS PRODUCTS MARKET FOR CROS & CDMOS, BY REGION, 2024–2031 (USD MILLION) 293 TABLE 382 GCC COUNTRIES: HTS PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024–2031 (USD MILLION) 294 TABLE 383 HTS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION) 295 TABLE 384 NORTH AMERICA: HTS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 295 TABLE 385 EUROPE: HTS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 296 TABLE 386 ASIA PACIFIC: HTS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 296 TABLE 387 LATIN AMERICA: HTS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 297 TABLE 388 MIDDLE EAST: HTS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION) 297 TABLE 389 GCC COUNTRIES: HTS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 297 TABLE 390 HTS PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION) 298 TABLE 391 NORTH AMERICA: HTS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 298 TABLE 392 EUROPE: HTS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 299 TABLE 393 ASIA PACIFIC: HTS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 299 TABLE 394 LATIN AMERICA: HTS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 300 TABLE 395 MIDDLE EAST: HTS PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION) 300 TABLE 396 GCC COUNTRIES: HTS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 300 TABLE 397 HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 302 TABLE 398 PRIMARY SCREENING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 303 TABLE 399 NORTH AMERICA: PRIMARY SCREENING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 303 TABLE 400 EUROPE: PRIMARY SCREENING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 304 TABLE 401 ASIA PACIFIC: PRIMARY SCREENING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 304 TABLE 402 LATIN AMERICA: PRIMARY SCREENING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 305 TABLE 403 MIDDLE EAST: PRIMARY SCREENING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 305 TABLE 404 GCC COUNTRIES: PRIMARY SCREENING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 305 TABLE 405 ASSAY DEVELOPMENT & OPTIMIZATION SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 306 TABLE 406 NORTH AMERICA: ASSAY DEVELOPMENT & OPTIMIZATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 307 TABLE 407 EUROPE: ASSAY DEVELOPMENT & OPTIMIZATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 307 TABLE 408 ASIA PACIFIC: ASSAY DEVELOPMENT & OPTIMIZATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 308 TABLE 409 LATIN AMERICA: ASSAY DEVELOPMENT & OPTIMIZATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 308 TABLE 410 MIDDLE EAST: ASSAY DEVELOPMENT & OPTIMIZATION SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 308 TABLE 411 GCC COUNTRIES: ASSAY DEVELOPMENT & OPTIMIZATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 309 TABLE 412 SECONDARY SCREENING & HIT CONFIRMATION SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 309 TABLE 413 NORTH AMERICA: SECONDARY SCREENING & HIT CONFIRMATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 310 TABLE 414 EUROPE: SECONDARY SCREENING & HIT CONFIRMATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 310 TABLE 415 ASIA PACIFIC: SECONDARY SCREENING & HIT CONFIRMATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 311 TABLE 416 LATIN AMERICA: SECONDARY SCREENING & HIT CONFIRMATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 311 TABLE 417 MIDDLE EAST: SECONDARY SCREENING & HIT CONFIRMATION SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 311 TABLE 418 GCC COUNTRIES: SECONDARY SCREENING & HIT CONFIRMATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 312 TABLE 419 HIT VALIDATION & CHARACTERIZATION SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 312 TABLE 420 NORTH AMERICA: HIT VALIDATION & CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 313 TABLE 421 EUROPE: HIT VALIDATION & CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 313 TABLE 422 ASIA PACIFIC: HIT VALIDATION & CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 314 TABLE 423 LATIN AMERICA: HIT VALIDATION & CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 314 TABLE 424 MIDDLE EAST: HIT VALIDATION & CHARACTERIZATION SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 314 TABLE 425 GCC COUNTRIES: HIT VALIDATION & CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 315 TABLE 426 COMPOUND LIBRARY MANAGEMENT SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 315 TABLE 427 NORTH AMERICA: COMPOUND LIBRARY MANAGEMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 316 TABLE 428 EUROPE: COMPOUND LIBRARY MANAGEMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 316 TABLE 429 ASIA PACIFIC: COMPOUND LIBRARY MANAGEMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 317 TABLE 430 LATIN AMERICA: COMPOUND LIBRARY MANAGEMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 317 TABLE 431 MIDDLE EAST: COMPOUND LIBRARY MANAGEMENT SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 317 TABLE 432 GCC COUNTRIES: COMPOUND LIBRARY MANAGEMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 318 TABLE 433 DATA ANALYSIS & INFORMATICS SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 319 TABLE 434 NORTH AMERICA: DATA ANALYSIS & INFORMATICS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 319 TABLE 435 EUROPE: DATA ANALYSIS & INFORMATICS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 320 TABLE 436 ASIA PACIFIC: DATA ANALYSIS & INFORMATICS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 320 TABLE 437 LATIN AMERICA: DATA ANALYSIS & INFORMATICS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 321 TABLE 438 MIDDLE EAST: DATA ANALYSIS & INFORMATICS SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 321 TABLE 439 GCC COUNTRIES: DATA ANALYSIS & INFORMATICS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 321 TABLE 440 OTHER HTS SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 322 TABLE 441 NORTH AMERICA: OTHER HTS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 322 TABLE 442 EUROPE: OTHER HTS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 323 TABLE 443 ASIA PACIFIC: OTHER HTS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 323 TABLE 444 LATIN AMERICA: OTHER HTS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 323 TABLE 445 MIDDLE EAST: OTHER HTS SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 324 TABLE 446 GCC COUNTRIES: OTHER HTS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 324 TABLE 447 HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 326 TABLE 448 HTS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION) 327 TABLE 449 NORTH AMERICA: HTS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 327 TABLE 450 EUROPE: HTS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 328 TABLE 451 ASIA PACIFIC: HTS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 328 TABLE 452 LATIN AMERICA: HTS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 329 TABLE 453 MIDDLE EAST: HTS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION) 329 TABLE 454 GCC COUNTRIES: HTS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 329 TABLE 455 HTS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION) 330 TABLE 456 NORTH AMERICA: HTS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 330 TABLE 457 EUROPE: HTS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 331 TABLE 458 ASIA PACIFIC: HTS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 331 TABLE 459 LATIN AMERICA: HTS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 332 TABLE 460 MIDDLE EAST: HTS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION) 332 TABLE 461 GCC COUNTRIES: HTS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 332 TABLE 462 HTS SERVICES MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION) 333 TABLE 463 NORTH AMERICA: HTS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 333 TABLE 464 EUROPE: HTS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 334 TABLE 465 ASIA PACIFIC: HTS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 334 TABLE 466 LATIN AMERICA: HTS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 335 TABLE 467 MIDDLE EAST: HTS SERVICES MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION) 335 TABLE 468 GCC COUNTRIES: HTS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 335 TABLE 469 HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 337 TABLE 470 HTS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2024–2031 (USD MILLION) 338 TABLE 471 NORTH AMERICA: HTS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 339 TABLE 472 EUROPE: HTS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 339 TABLE 473 ASIA PACIFIC: HTS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 340 TABLE 474 LATIN AMERICA: HTS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 340 TABLE 475 MIDDLE EAST: HTS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2024–2031 (USD MILLION) 340 TABLE 476 GCC COUNTRIES: HTS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 341 TABLE 477 HTS MARKET FOR BASIC RESEARCH & FUNCTIONAL GENOMICS, BY REGION, 2024–2031 (USD MILLION) 342 TABLE 478 NORTH AMERICA: HTS MARKET FOR BASIC RESEARCH & FUNCTIONAL GENOMICS, BY COUNTRY, 2024–2031 (USD MILLION) 342 TABLE 479 EUROPE: HTS MARKET FOR BASIC RESEARCH & FUNCTIONAL GENOMICS, BY COUNTRY, 2024–2031 (USD MILLION) 343 TABLE 480 ASIA PACIFIC: HTS MARKET FOR BASIC RESEARCH & FUNCTIONAL GENOMICS, BY COUNTRY, 2024–2031 (USD MILLION) 343 TABLE 481 LATIN AMERICA: HTS MARKET FOR BASIC RESEARCH & FUNCTIONAL GENOMICS, BY COUNTRY, 2024–2031 (USD MILLION) 344 TABLE 482 MIDDLE EAST: HTS MARKET FOR BASIC RESEARCH & FUNCTIONAL GENOMICS, BY REGION, 2024–2031 (USD MILLION) 344 TABLE 483 GCC COUNTRIES: HTS MARKET FOR BASIC RESEARCH & FUNCTIONAL GENOMICS, BY COUNTRY, 2024–2031 (USD MILLION) 344 TABLE 484 HTS MARKET FOR TOXICOLOGY & SAFETY SCREENING, BY REGION, 2024–2031 (USD MILLION) 345 TABLE 485 NORTH AMERICA: HTS MARKET FOR TOXICOLOGY & SAFETY SCREENING, BY COUNTRY, 2024–2031 (USD MILLION) 345 TABLE 486 EUROPE: HTS MARKET FOR TOXICOLOGY & SAFETY SCREENING, BY COUNTRY, 2024–2031 (USD MILLION) 346 TABLE 487 ASIA PACIFIC: HTS MARKET FOR TOXICOLOGY & SAFETY SCREENING, BY COUNTRY, 2024–2031 (USD MILLION) 346 TABLE 488 LATIN AMERICA: HTS MARKET FOR TOXICOLOGY & SAFETY SCREENING, BY COUNTRY, 2024–2031 (USD MILLION) 347 TABLE 489 MIDDLE EAST: HTS MARKET FOR TOXICOLOGY & SAFETY SCREENING, BY REGION, 2024–2031 (USD MILLION) 347 TABLE 490 GCC COUNTRIES: HTS MARKET FOR TOXICOLOGY & SAFETY SCREENING, BY COUNTRY, 2024–2031 (USD MILLION) 347 TABLE 491 HTS MARKET FOR PRECISION MEDICINE & BIOMARKER DISCOVERY, BY REGION, 2024–2031 (USD MILLION) 348 TABLE 492 NORTH AMERICA: HTS MARKET FOR PRECISION MEDICINE & BIOMARKER DISCOVERY, BY COUNTRY, 2024–2031 (USD MILLION) 348 TABLE 493 EUROPE: HTS MARKET FOR PRECISION MEDICINE & BIOMARKER DISCOVERY, BY COUNTRY, 2024–2031 (USD MILLION) 349 TABLE 494 ASIA PACIFIC: HTS MARKET FOR PRECISION MEDICINE & BIOMARKER DISCOVERY, BY COUNTRY, 2024–2031 (USD MILLION) 349 TABLE 495 LATIN AMERICA: HTS MARKET FOR PRECISION MEDICINE & BIOMARKER DISCOVERY, BY COUNTRY, 2024–2031 (USD MILLION) 350 TABLE 496 MIDDLE EAST: HTS MARKET FOR PRECISION MEDICINE & BIOMARKER DISCOVERY, BY REGION, 2024–2031 (USD MILLION) 350 TABLE 497 GCC COUNTRIES: HTS MARKET FOR PRECISION MEDICINE & BIOMARKER DISCOVERY, BY COUNTRY, 2024–2031 (USD MILLION) 350 TABLE 498 HTS MARKET FOR STEM CELL & REGENERATIVE MEDICINE RESEARCH, BY REGION, 2024–2031 (USD MILLION) 351 TABLE 499 NORTH AMERICA: HTS MARKET FOR STEM CELL & REGENERATIVE MEDICINE RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION) 351 TABLE 500 EUROPE: HTS MARKET FOR STEM CELL & REGENERATIVE MEDICINE RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION) 352 TABLE 501 ASIA PACIFIC: HTS MARKET FOR STEM CELL & REGENERATIVE MEDICINE RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION) 352 TABLE 502 LATIN AMERICA: HTS MARKET FOR STEM CELL & REGENERATIVE MEDICINE RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION) 353 TABLE 503 MIDDLE EAST: HTS MARKET FOR STEM CELL & REGENERATIVE MEDICINE RESEARCH, BY REGION, 2024–2031 (USD MILLION) 353 TABLE 504 GCC COUNTRIES: HTS MARKET FOR STEM CELL & REGENERATIVE MEDICINE RESEARCH, BY COUNTRY, 2024–2031 (USD MILLION) 353 TABLE 505 HTS MARKET FOR OTHER APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 354 TABLE 506 NORTH AMERICA: HTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 354 TABLE 507 EUROPE: HTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 355 TABLE 508 ASIA PACIFIC: HTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 355 TABLE 509 LATIN AMERICA: HTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 356 TABLE 510 MIDDLE EAST: HTS MARKET FOR OTHER APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 356 TABLE 511 GCC COUNTRIES: HTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 356 TABLE 512 HIGH-THROUGHPUT SCREENING MARKET, BY REGION, 2024–2031 (USD MILLION) 358 TABLE 513 HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY REGION, 2024–2031 (USD MILLION) 358 TABLE 514 HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 359 TABLE 515 NORTH AMERICA: HIGH-THROUGHPUT SCREENING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 360 TABLE 516 NORTH AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 361 TABLE 517 NORTH AMERICA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 361 TABLE 518 NORTH AMERICA: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION) 361 TABLE 519 NORTH AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 362 TABLE 520 NORTH AMERICA: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 362 TABLE 521 NORTH AMERICA: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 363 TABLE 522 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 363 TABLE 523 NORTH AMERICA: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 363 TABLE 524 NORTH AMERICA: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 364 TABLE 525 NORTH AMERICA: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 364 TABLE 526 NORTH AMERICA: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 365 TABLE 527 NORTH AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 365 TABLE 528 NORTH AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 366 TABLE 529 NORTH AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 366 TABLE 530 NORTH AMERICA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 367 TABLE 531 NORTH AMERICA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 367 TABLE 532 NORTH AMERICA: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 368 TABLE 533 US: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION) 369 TABLE 534 US: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 369 TABLE 535 US: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 369 TABLE 536 US: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 370 TABLE 537 US: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 370 TABLE 538 US: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 370 TABLE 539 US: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 371 TABLE 540 US: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 371 TABLE 541 US: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 372 TABLE 542 US: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 372 TABLE 543 US: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 373 TABLE 544 US: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 373 TABLE 545 US: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 374 TABLE 546 US: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 374 TABLE 547 US: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 375 TABLE 548 CANADA: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION) 376 TABLE 549 CANADA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 376 TABLE 550 CANADA: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 377 TABLE 551 CANADA: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 377 TABLE 552 CANADA: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 378 TABLE 553 CANADA: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 378 TABLE 554 CANADA: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 378 TABLE 555 CANADA: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 379 TABLE 556 CANADA: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 379 TABLE 557 CANADA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 380 TABLE 558 CANADA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 380 TABLE 559 CANADA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 381 TABLE 560 CANADA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 381 TABLE 561 CANADA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 382 TABLE 562 CANADA: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 382 TABLE 563 EUROPE: HIGH-THROUGHPUT SCREENING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 383 TABLE 564 EUROPE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 384 TABLE 565 EUROPE: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 384 TABLE 566 EUROPE: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION) 385 TABLE 567 EUROPE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 385 TABLE 568 EUROPE: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 386 TABLE 569 EUROPE: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 386 TABLE 570 EUROPE: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 387 TABLE 571 EUROPE: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 387 TABLE 572 EUROPE: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 387 TABLE 573 EUROPE: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 388 TABLE 574 EUROPE: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 388 TABLE 575 EUROPE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 389 TABLE 576 EUROPE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 389 TABLE 577 EUROPE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 390 TABLE 578 EUROPE: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 390 TABLE 579 EUROPE: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 391 TABLE 580 EUROPE: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 391 TABLE 581 GERMANY: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION) 392 TABLE 582 GERMANY: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 393 TABLE 583 GERMANY: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 393 TABLE 584 GERMANY: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 393 TABLE 585 GERMANY: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 394 TABLE 586 GERMANY: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 394 TABLE 587 GERMANY: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 394 TABLE 588 GERMANY: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 395 TABLE 589 GERMANY: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 395 TABLE 590 GERMANY: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 396 TABLE 591 GERMANY: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 396 TABLE 592 GERMANY: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 397 TABLE 593 GERMANY: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 397 TABLE 594 GERMANY: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 398 TABLE 595 GERMANY: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 398 TABLE 596 UK: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION) 399 TABLE 597 UK: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 400 TABLE 598 UK: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 400 TABLE 599 UK: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 401 TABLE 600 UK: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 401 TABLE 601 UK: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 401 TABLE 602 UK: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 402 TABLE 603 UK: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 402 TABLE 604 UK: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 403 TABLE 605 UK: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 403 TABLE 606 UK: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 404 TABLE 607 UK: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 404 TABLE 608 UK: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 405 TABLE 609 UK: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 405 TABLE 610 UK: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 406 TABLE 611 FRANCE: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION) 407 TABLE 612 FRANCE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 407 TABLE 613 FRANCE: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 408 TABLE 614 FRANCE: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 408 TABLE 615 FRANCE: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 408 TABLE 616 FRANCE: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 409 TABLE 617 FRANCE: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 409 TABLE 618 FRANCE: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 410 TABLE 619 FRANCE: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 410 TABLE 620 FRANCE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 411 TABLE 621 FRANCE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 411 TABLE 622 FRANCE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 412 TABLE 623 FRANCE: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 412 TABLE 624 FRANCE: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 413 TABLE 625 FRANCE: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 413 TABLE 626 ITALY: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION) 414 TABLE 627 ITALY: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 414 TABLE 628 ITALY: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 415 TABLE 629 ITALY: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 415 TABLE 630 ITALY: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 415 TABLE 631 ITALY: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 416 TABLE 632 ITALY: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 416 TABLE 633 ITALY: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 417 TABLE 634 ITALY: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 417 TABLE 635 ITALY: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 418 TABLE 636 ITALY: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 418 TABLE 637 ITALY: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 419 TABLE 638 ITALY: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 419 TABLE 639 ITALY: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 420 TABLE 640 ITALY: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 420 TABLE 641 SPAIN: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION) 421 TABLE 642 SPAIN: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 421 TABLE 643 SPAIN: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 422 TABLE 644 SPAIN: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 422 TABLE 645 SPAIN: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 422 TABLE 646 SPAIN: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 423 TABLE 647 SPAIN: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 423 TABLE 648 SPAIN: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 424 TABLE 649 SPAIN: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 424 TABLE 650 SPAIN: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 425 TABLE 651 SPAIN: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 425 TABLE 652 SPAIN: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 426 TABLE 653 SPAIN: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 426 TABLE 654 SPAIN: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 427 TABLE 655 SPAIN: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 427 TABLE 656 REST OF EUROPE: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION) 428 TABLE 657 REST OF EUROPE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 428 TABLE 658 REST OF EUROPE: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 429 TABLE 659 REST OF EUROPE: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 429 TABLE 660 REST OF EUROPE: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 430 TABLE 661 REST OF EUROPE: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 430 TABLE 662 REST OF EUROPE: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 430 TABLE 663 REST OF EUROPE: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 431 TABLE 664 REST OF EUROPE: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 431 TABLE 665 REST OF EUROPE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 432 TABLE 666 REST OF EUROPE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 432 TABLE 667 REST OF EUROPE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 433 TABLE 668 REST OF EUROPE: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 433 TABLE 669 REST OF EUROPE: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 434 TABLE 670 REST OF EUROPE: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 434 TABLE 671 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 436 TABLE 672 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 436 TABLE 673 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 437 TABLE 674 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION) 437 TABLE 675 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 437 TABLE 676 ASIA PACIFIC: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 438 TABLE 677 ASIA PACIFIC: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 438 TABLE 678 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 438 TABLE 679 ASIA PACIFIC: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 439 TABLE 680 ASIA PACIFIC: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 439 TABLE 681 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 440 TABLE 682 ASIA PACIFIC: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 440 TABLE 683 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 441 TABLE 684 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 441 TABLE 685 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 442 TABLE 686 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 442 TABLE 687 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 443 TABLE 688 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 443 TABLE 689 CHINA: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION) 444 TABLE 690 CHINA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 444 TABLE 691 CHINA: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 445 TABLE 692 CHINA: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 445 TABLE 693 CHINA: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 445 TABLE 694 CHINA: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 446 TABLE 695 CHINA: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 446 TABLE 696 CHINA: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 447 TABLE 697 CHINA: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 447 TABLE 698 CHINA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 448 TABLE 699 CHINA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 448 TABLE 700 CHINA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 449 TABLE 701 CHINA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 449 TABLE 702 CHINA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 450 TABLE 703 CHINA: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 450 TABLE 704 JAPAN: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION) 451 TABLE 705 JAPAN: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 451 TABLE 706 JAPAN: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 452 TABLE 707 JAPAN: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 452 TABLE 708 JAPAN: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 453 TABLE 709 JAPAN: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 453 TABLE 710 JAPAN: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 453 TABLE 711 JAPAN: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 454 TABLE 712 JAPAN: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 454 TABLE 713 JAPAN: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 455 TABLE 714 JAPAN: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 455 TABLE 715 JAPAN: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 456 TABLE 716 JAPAN: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 456 TABLE 717 JAPAN: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 457 TABLE 718 JAPAN: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 457 TABLE 719 INDIA: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION) 458 TABLE 720 INDIA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 458 TABLE 721 INDIA: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 459 TABLE 722 INDIA: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 459 TABLE 723 INDIA: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 460 TABLE 724 INDIA: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 460 TABLE 725 INDIA: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 460 TABLE 726 INDIA: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 461 TABLE 727 INDIA: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 461 TABLE 728 INDIA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 462 TABLE 729 INDIA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 462 TABLE 730 INDIA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 463 TABLE 731 INDIA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 463 TABLE 732 INDIA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 464 TABLE 733 INDIA: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 464 TABLE 734 AUSTRALIA: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION) 465 TABLE 735 AUSTRALIA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 465 TABLE 736 AUSTRALIA: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 466 TABLE 737 AUSTRALIA: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 466 TABLE 738 AUSTRALIA: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 467 TABLE 739 AUSTRALIA: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 467 TABLE 740 AUSTRALIA: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 467 TABLE 741 AUSTRALIA: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 468 TABLE 742 AUSTRALIA: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 468 TABLE 743 AUSTRALIA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 469 TABLE 744 AUSTRALIA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 469 TABLE 745 AUSTRALIA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 470 TABLE 746 AUSTRALIA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 470 TABLE 747 AUSTRALIA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 471 TABLE 748 AUSTRALIA: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 471 TABLE 749 SOUTH KOREA: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION) 472 TABLE 750 SOUTH KOREA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 472 TABLE 751 SOUTH KOREA: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 473 TABLE 752 SOUTH KOREA: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 473 TABLE 753 SOUTH KOREA: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 474 TABLE 754 SOUTH KOREA: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 474 TABLE 755 SOUTH KOREA: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 474 TABLE 756 SOUTH KOREA: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 475 TABLE 757 SOUTH KOREA: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 475 TABLE 758 SOUTH KOREA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 476 TABLE 759 SOUTH KOREA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 476 TABLE 760 SOUTH KOREA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 477 TABLE 761 SOUTH KOREA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 477 TABLE 762 SOUTH KOREA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 478 TABLE 763 SOUTH KOREA: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 478 TABLE 764 REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION) 479 TABLE 765 REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 479 TABLE 766 REST OF ASIA PACIFIC: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 480 TABLE 767 REST OF ASIA PACIFIC: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 480 TABLE 768 REST OF ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 481 TABLE 769 REST OF ASIA PACIFIC: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 481 TABLE 770 REST OF ASIA PACIFIC: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 481 TABLE 771 REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 482 TABLE 772 REST OF ASIA PACIFIC: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 482 TABLE 773 REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 483 TABLE 774 REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 483 TABLE 775 REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 484 TABLE 776 REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 484 TABLE 777 REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 485 TABLE 778 REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 485 TABLE 779 LATIN AMERICA: HIGH-THROUGHPUT SCREENING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 486 TABLE 780 LATIN AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 486 TABLE 781 LATIN AMERICA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 487 TABLE 782 LATIN AMERICA: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION) 487 TABLE 783 LATIN AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 487 TABLE 784 LATIN AMERICA: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 488 TABLE 785 LATIN AMERICA: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 488 TABLE 786 LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 488 TABLE 787 LATIN AMERICA: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 489 TABLE 788 LATIN AMERICA: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 489 TABLE 789 LATIN AMERICA: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 490 TABLE 790 LATIN AMERICA: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 490 TABLE 791 LATIN AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 491 TABLE 792 LATIN AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 491 TABLE 793 LATIN AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 492 TABLE 794 LATIN AMERICA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 492 TABLE 795 LATIN AMERICA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 493 TABLE 796 LATIN AMERICA: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 493 TABLE 797 BRAZIL: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION) 494 TABLE 798 BRAZIL: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 494 TABLE 799 BRAZIL: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 495 TABLE 800 BRAZIL: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 495 TABLE 801 BRAZIL: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 496 TABLE 802 BRAZIL: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 496 TABLE 803 BRAZIL: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 496 TABLE 804 BRAZIL: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 497 TABLE 805 BRAZIL: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 497 TABLE 806 BRAZIL: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 498 TABLE 807 BRAZIL: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 498 TABLE 808 BRAZIL: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 499 TABLE 809 BRAZIL: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 499 TABLE 810 BRAZIL: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 500 TABLE 811 BRAZIL: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 500 TABLE 812 MEXICO: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION) 501 TABLE 813 MEXICO: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 501 TABLE 814 MEXICO: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 502 TABLE 815 MEXICO: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 502 TABLE 816 MEXICO: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 502 TABLE 817 MEXICO: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 503 TABLE 818 MEXICO: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 503 TABLE 819 MEXICO: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 504 TABLE 820 MEXICO: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 504 TABLE 821 MEXICO: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 505 TABLE 822 MEXICO: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 505 TABLE 823 MEXICO: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 506 TABLE 824 MEXICO: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 506 TABLE 825 MEXICO: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 507 TABLE 826 MEXICO: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 507 TABLE 827 REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION) 508 TABLE 828 REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 508 TABLE 829 REST OF LATIN AMERICA: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 509 TABLE 830 REST OF LATIN AMERICA: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 509 TABLE 831 REST OF LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 510 TABLE 832 REST OF LATIN AMERICA: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 510 TABLE 833 REST OF LATIN AMERICA: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 510 TABLE 834 REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 511 TABLE 835 REST OF LATIN AMERICA: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 511 TABLE 836 REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 512 TABLE 837 REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 512 TABLE 838 REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 513 TABLE 839 REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 513 TABLE 840 REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 514 TABLE 841 REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 514 TABLE 842 MIDDLE EAST: HIGH-THROUGHPUT SCREENING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 515 TABLE 843 MIDDLE EAST: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 515 TABLE 844 MIDDLE EAST: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 516 TABLE 845 MIDDLE EAST: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION) 516 TABLE 846 MIDDLE EAST: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 516 TABLE 847 MIDDLE EAST: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 517 TABLE 848 MIDDLE EAST: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 517 TABLE 849 MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 517 TABLE 850 MIDDLE EAST: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 518 TABLE 851 MIDDLE EAST: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 518 TABLE 852 MIDDLE EAST: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 519 TABLE 853 MIDDLE EAST: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 519 TABLE 854 MIDDLE EAST: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 520 TABLE 855 MIDDLE EAST: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 520 TABLE 856 MIDDLE EAST: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 521 TABLE 857 MIDDLE EAST: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 521 TABLE 858 MIDDLE EAST: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 522 TABLE 859 MIDDLE EAST: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 522 TABLE 860 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 523 TABLE 861 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 523 TABLE 862 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 523 TABLE 863 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION) 524 TABLE 864 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 524 TABLE 865 GCC COUNTRIES: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 524 TABLE 866 GCC COUNTRIES: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 525 TABLE 867 GCC COUNTRIES: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 525 TABLE 868 GCC COUNTRIES: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 525 TABLE 869 GCC COUNTRIES: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 526 TABLE 870 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 526 TABLE 871 GCC COUNTRIES: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 527 TABLE 872 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 527 TABLE 873 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 528 TABLE 874 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 528 TABLE 875 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 529 TABLE 876 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 529 TABLE 877 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 530 TABLE 878 SAUDI ARABIA: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION) 530 TABLE 879 SAUDI ARABIA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 531 TABLE 880 SAUDI ARABIA: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 531 TABLE 881 SAUDI ARABIA: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 531 TABLE 882 SAUDI ARABIA: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 532 TABLE 883 SAUDI ARABIA: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 532 TABLE 884 SAUDI ARABIA: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 532 TABLE 885 SAUDI ARABIA: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 533 TABLE 886 SAUDI ARABIA: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 533 TABLE 887 SAUDI ARABIA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 534 TABLE 888 SAUDI ARABIA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 534 TABLE 889 SAUDI ARABIA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 535 TABLE 890 SAUDI ARABIA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 535 TABLE 891 SAUDI ARABIA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 536 TABLE 892 SAUDI ARABIA: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 536 TABLE 893 UAE: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION) 537 TABLE 894 UAE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 537 TABLE 895 UAE: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 538 TABLE 896 UAE: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 538 TABLE 897 UAE: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 538 TABLE 898 UAE: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 539 TABLE 899 UAE: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 539 TABLE 900 UAE: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 540 TABLE 901 UAE: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 540 TABLE 902 UAE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 541 TABLE 903 UAE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 541 TABLE 904 UAE: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 542 TABLE 905 UAE: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 542 TABLE 906 UAE: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 543 TABLE 907 UAE: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 543 TABLE 908 REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION) 544 TABLE 909 REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 544 TABLE 910 REST OF GCC COUNTRIES: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 545 TABLE 911 REST OF GCC COUNTRIES: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 545 TABLE 912 REST OF GCC COUNTRIES: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 546 TABLE 913 REST OF GCC COUNTRIES: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 546 TABLE 914 REST OF GCC COUNTRIES: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 546 TABLE 915 REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 547 TABLE 916 REST OF GCC COUNTRIES: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 547 TABLE 917 REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 548 TABLE 918 REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 548 TABLE 919 REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 549 TABLE 920 REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 549 TABLE 921 REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 550 TABLE 922 REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 550 TABLE 923 REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION) 551 TABLE 924 REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 551 TABLE 925 REST OF MIDDLE EAST: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 552 TABLE 926 REST OF MIDDLE EAST: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 552 TABLE 927 REST OF MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 553 TABLE 928 REST OF MIDDLE EAST: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 553 TABLE 929 REST OF MIDDLE EAST: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 553 TABLE 930 REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 554 TABLE 931 REST OF MIDDLE EAST: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 554 TABLE 932 REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 555 TABLE 933 REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 555 TABLE 934 REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 556 TABLE 935 REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 556 TABLE 936 REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 557 TABLE 937 REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 557 TABLE 938 AFRICA: HIGH-THROUGHPUT SCREENING MARKET, BY OFFERING, 2024–2031 (USD MILLION) 558 TABLE 939 AFRICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 558 TABLE 940 AFRICA: REAGENTS, KITS, AND CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 559 TABLE 941 AFRICA: SCREENING ASSAY KITS MARKET, BY TYPE, 2024–2031 (USD MILLION) 559 TABLE 942 AFRICA: CELL-BASED ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 559 TABLE 943 AFRICA: BIOCHEMICAL ASSAYS MARKET, BY TYPE, 2024–2031 (USD MILLION) 560 TABLE 944 AFRICA: 3D CELL CULTURE PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 560 TABLE 945 AFRICA: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 561 TABLE 946 AFRICA: DETECTION & IMAGING SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 561 TABLE 947 AFRICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 562 TABLE 948 AFRICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 562 TABLE 949 AFRICA: HIGH-THROUGHPUT SCREENING PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 563 TABLE 950 AFRICA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 563 TABLE 951 AFRICA: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 564 TABLE 952 AFRICA: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 564 TABLE 953 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN HIGH-THROUGHPUT SCREENING MARKET 566 TABLE 954 HIGH-THROUGHPUT SCREENING MARKET: DEGREE OF COMPETITION 569 TABLE 955 HIGH-THROUGHPUT SCREENING MARKET: REGION FOOTPRINT 574 TABLE 956 HIGH-THROUGHPUT SCREENING MARKET: OFFERING FOOTPRINT 575 TABLE 957 HIGH-THROUGHPUT SCREENING MARKET: PRODUCT TYPE FOOTPRINT 576 TABLE 958 HIGH-THROUGHPUT SCREENING MARKET: APPLICATION FOOTPRINT 577 TABLE 959 HIGH-THROUGHPUT SCREENING MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS 580 TABLE 960 HIGH-THROUGHPUT SCREENING MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SME PLAYERS, BY OFFERING AND REGION 581 TABLE 961 HIGH-THROUGHPUT SCREENING MARKET: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026 584 TABLE 962 HIGH-THROUGHPUT SCREENING MARKET: DEALS, JANUARY 2023–APRIL 2026 585 TABLE 963 HIGH-THROUGHPUT SCREENING MARKET: EXPANSIONS, JANUARY 2023–APRIL 2026 586 TABLE 964 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 587 TABLE 965 THERMO FISHER SCIENTIFIC INC.: PRODUCTS & SERVICES OFFERED 588 TABLE 966 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026 591 TABLE 967 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2023–APRIL 2026 593 TABLE 968 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2023–APRIL 2026 594 TABLE 969 DANAHER CORPORATION: COMPANY OVERVIEW 596 TABLE 970 DANAHER CORPORATION: PRODUCTS & SERVICES OFFERED 597 TABLE 971 DANAHER CORPORATION: PRODUCT & SERVICE LAUNCHES, JANUARY 2023–APRIL 2026 601 TABLE 972 DANAHER CORPORATION: DEALS, JANUARY 2023–APRIL 2026 601 TABLE 973 MERCK KGAA: COMPANY OVERVIEW 603 TABLE 974 MERCK KGAA: PRODUCTS & SERVICES OFFERED 604 TABLE 975 MERCK KGAA: DEALS, JANUARY 2023–APRIL 2026 606 TABLE 976 MERCK KGAA: EXPANSIONS, JANUARY 2023–APRIL 2026 607 TABLE 977 MERCK KGAA: OTHER DEVELOPMENTS, JANUARY 2023–APRIL 2026 607 TABLE 978 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW 609 TABLE 979 AGILENT TECHNOLOGIES, INC.: PRODUCTS & SERVICES OFFERED 610 TABLE 980 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023–APRIL 2026 614 TABLE 981 AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2023–APRIL 2026 615 TABLE 982 AGILENT TECHNOLOGIES, INC.: EXPANSIONS, JANUARY 2023–APRIL 2026 616 TABLE 983 AGILENT TECHNOLOGIES, INC.: OTHER DEVELOPMENTS, JANUARY 2023–APRIL 2026 616 TABLE 984 REVVITY, INC.: COMPANY OVERVIEW 618 TABLE 985 REVVITY INC.: PRODUCTS & SERVICES OFFERED 619 TABLE 986 REVVITY, INC.: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026 622 TABLE 987 REVVITY, INC.: DEALS, JANUARY 2023–APRIL 2026 623 TABLE 988 TECAN GROUP LTD.: COMPANY OVERVIEW 624 TABLE 989 TECAN GROUP LTD.: PRODUCTS & SERVICES OFFERED 625 TABLE 990 TECAN GROUP LTD.: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026 627 TABLE 991 TECAN GROUP LTD.: DEALS, JANUARY 2023–APRIL 2026 627 TABLE 992 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 628 TABLE 993 BIO-RAD LABORATORIES, INC.: PRODUCTS & SERVICES OFFERED 629 TABLE 994 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026 632 TABLE 995 CORNING INCORPORATED: COMPANY OVERVIEW 633 TABLE 996 CORNING INCORPORATED: PRODUCTS & SERVICES OFFERED 634 TABLE 997 METTLER-TOLEDO INTERNATIONAL INC.: COMPANY OVERVIEW 636 TABLE 998 METTLER-TOLEDO INTERNATIONAL INC.: PRODUCTS & SERVICES OFFERED 637 TABLE 999 LONZA GROUP: COMPANY OVERVIEW 639 TABLE 1000 LONZA GROUP: PRODUCTS & SERVICES OFFERED 640 TABLE 1001 WATERS CORPORATION: COMPANY OVERVIEW 641 TABLE 1002 WATERS CORPORATION: PRODUCTS & SERVICES OFFERED 642 TABLE 1003 WATERS CORPORATION: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026 644 TABLE 1004 WATERS CORPORATION: DEALS, JANUARY 2023–APRIL 2026 645 TABLE 1005 SARTORIUS AG: COMPANY OVERVIEW 646 TABLE 1006 SARTORIUS AG: PRODUCTS & SERVICES OFFERED 647 TABLE 1007 SARTORIUS AG: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026 652 TABLE 1008 SARTORIUS AG: DEALS, JANUARY 2023–APRIL 2026 652 TABLE 1009 SARTORIUS AG: EXPANSIONS, JANUARY 2023–APRIL 2026 652 TABLE 1010 EPPENDORF SE: COMPANY OVERVIEW 653 TABLE 1011 EPPENDORF SE: PRODUCTS & SERVICES OFFERED 654 TABLE 1012 EPPENDORF SE: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026 656 TABLE 1013 EPPENDORF SE: DEALS, JANUARY 2023–APRIL 2026 656 TABLE 1014 EPPENDORF SE: EXPANSIONS, JANUARY 2023–APRIL 2026 657 TABLE 1015 PORVAIR PLC: COMPANY OVERVIEW 658 TABLE 1016 PORVAIR PLC: PRODUCTS & SERVICES OFFERED 660 TABLE 1017 GREINER AG: COMPANY OVERVIEW 661 TABLE 1018 GREINER AG: PRODUCTS & SERVICES OFFERED 662 TABLE 1019 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY OVERVIEW 665 TABLE 1020 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: PRODUCTS & SERVICES OFFERED 667 TABLE 1021 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: DEALS, JANUARY 2023–APRIL 2026 667 TABLE 1022 EUROFINS SCIENTIFIC: COMPANY OVERVIEW 668 TABLE 1023 EUROFINS SCIENTIFIC: PRODUCTS & SERVICES OFFERED 669 TABLE 1024 EUROFINS SCIENTIFIC: SERVICE LAUNCHES 671 TABLE 1025 EUROFINS SCIENTIFIC: DEALS, JANUARY 2023–APRIL 2026 671 TABLE 1026 EUROFINS SCIENTIFIC: EXPANSIONS, JANUARY 2023–APRIL 2026 671 TABLE 1027 HAMILTON COMPANY: COMPANY OVERVIEW 672 TABLE 1028 HAMILTON COMPANY: PRODUCTS & SERVICES OFFERED 672 TABLE 1029 HAMILTON COMPANY: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026 673 TABLE 1030 HAMILTON COMPANY: DEALS, JANUARY 2023–APRIL 2026 674 TABLE 1031 AURORA BIOMED INC.: COMPANY OVERVIEW 675 TABLE 1032 AURORA BIOMED INC.: PRODUCTS & SERVICES OFFERED 675 TABLE 1033 GILSON INCORPORATED: COMPANY OVERVIEW 676 TABLE 1034 GILSON INCORPORATED: PRODUCTS & SERVICES OFFERED 676 TABLE 1035 BRAND GMBH + CO KG: COMPANY OVERVIEW 682 TABLE 1036 BRAND GMBH + CO KG: PRODUCTS & SERVICES OFFERED 682 TABLE 1037 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS 705 TABLE 1038 RISK ASSESSMENT 708 FIGURE 1 HTS MARKET SEGMENTATION 61 FIGURE 2 REGIONS CONSIDERED 62 FIGURE 3 HIGH-THROUGHPUT SCREENING MARKET: YEARS CONSIDERED 64 FIGURE 4 MARKET SCENARIO 66 FIGURE 5 GLOBAL HIGH-THROUGHPUT SCREENING MARKET, 2024–2031 67 FIGURE 6 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN HIGH-THROUGHPUT SCREENING MARKET, 2023–2026 67 FIGURE 7 DISRUPTIONS INFLUENCING GROWTH OF HIGH-THROUGHPUT SCREENING MARKET 68 FIGURE 8 HIGH-GROWTH SEGMENTS IN HIGH-THROUGHPUT SCREENING MARKET, 2026–2031 69 FIGURE 9 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN HIGH-THROUGHPUT SCREENING MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD 70 FIGURE 10 GROWING ADOPTION OF OPEN INNOVATIVE MODELS TO DRIVE MARKET GROWTH 72 FIGURE 11 US AND REAGENTS, KITS, AND CONSUMABLES ACCOUNTED FOR LARGEST SHARE OF HIGH-THROUGHPUT SCREENING MARKET IN NORTH AMERICA IN 2025 73 FIGURE 12 ASIA PACIFIC LIKELY TO BE FASTEST-GROWING MARKET IN GLOBAL HIGH-THROUGHPUT SCREENING MARKET DURING FORECAST PERIOD 74 FIGURE 13 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE MARKET DURING FORECAST PERIOD 75 FIGURE 14 HIGH-THROUGHPUT SCREENING (HTS) MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 77 FIGURE 15 HIGH-THROUGHPUT SCREENING (HTS) MARKET: PORTER’S FIVE FORCES ANALYSIS 86 FIGURE 16 GLOBAL GDP GROWTH (2020–2030) 89 FIGURE 17 HIGH-THROUGHPUT SCREENING (HTS) MARKET: VALUE CHAIN ANALYSIS 90 FIGURE 18 HIGH-THROUGHPUT SCREENING (HTS) MARKET ECOSYSTEM 91 FIGURE 19 AVERAGE SELLING PRICE TREND OF LIQUID HANDLING SYSTEMS, BY KEY PLAYER, 2023–2025 (USD) 94 FIGURE 20 AVERAGE SELLING PRICE OF PRODUCTS, BY REGION, 2025 (USD) 95 FIGURE 21 REVENUE SHIFT AND NEW REVENUE POCKETS FOR PLAYERS IN HIGH-THROUGHPUT SCREENING (HTS) MARKET 103 FIGURE 22 TOP APPLICANTS/OWNERS (COMPANIES) FOR HIGH-THROUGHPUT SCREENING PATENTS, 2015–2025 113 FIGURE 23 IMPACT OF AI/GEN AI ON HIGH-THROUGHPUT SCREENING (HTS) MARKET 117 FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING 125 FIGURE 25 KEY BUYING CRITERIA, BY END USER 126 FIGURE 26 FLOW CYTOMETRY INSTRUMENTS (CELL ANALYZERS) MARKET, 2024–2031 (UNITS) 218 FIGURE 27 NORTH AMERICA: HIGH-THROUGHPUT SCREENING MARKET SNAPSHOT 360 FIGURE 28 ASIA PACIFIC: HIGHT-THROUGHPUT SCREENING MARKET SNAPSHOT 435 FIGURE 29 REVENUE ANALYSIS OF KEY PLAYERS, 2021–2025 (USD MILLION) 568 FIGURE 30 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025 569 FIGURE 31 HIGH-THROUGHPUT SCREENING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 572 FIGURE 32 HIGH-THROUGHPUT SCREENING MARKET: COMPANY FOOTPRINT 573 FIGURE 33 HIGH-THROUGHPUT SCREENING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 579 FIGURE 34 EV/EBITDA OF KEY VENDORS 581 FIGURE 35 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 582 FIGURE 36 HIGH-THROUGHPUT SCREENING MARKET: BRAND/PRODUCT/SERVICE COMPARATIVE ANALYSIS 583 FIGURE 37 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025) 588 FIGURE 38 DANAHER CORPORATION: COMPANY SNAPSHOT (2025) 597 FIGURE 39 MERCK KGAA: COMPANY SNAPSHOT (2025) 604 FIGURE 40 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2025) 610 FIGURE 41 REVVITY, INC.: COMPANY SNAPSHOT (2025) 619 FIGURE 42 TECAN GROUP LTD.: COMPANY SNAPSHOT (2025) 625 FIGURE 43 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2025) 629 FIGURE 44 CORNING INCORPORATED: COMPANY SNAPSHOT (2025) 634 FIGURE 45 METTLER-TOLEDO INTERNATIONAL INC.: COMPANY SNAPSHOT (2025) 637 FIGURE 46 LONZA GROUP: COMPANY SNAPSHOT (2025) 640 FIGURE 47 WATERS CORPORATION: COMPANY SNAPSHOT (2025) 642 FIGURE 48 SARTORIUS AG: COMPANY SNAPSHOT (2025) 647 FIGURE 49 EPPENDORF SE: COMPANY SNAPSHOT (2024) 654 FIGURE 50 PORVAIR PLC: COMPANY SNAPSHOT (2025) 659 FIGURE 51 GREINER AG: COMPANY SNAPSHOT (2025) 662 FIGURE 52 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY SNAPSHOT (2025) 666 FIGURE 53 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2025) 669 FIGURE 54 HIGHT-THROUGHPUT SCREENING MARKET: RESEARCH DESIGN 695 FIGURE 55 HIGHT-THROUGHPUT SCREENING MARKET: BREAKDOWN OF PRIMARIES 697 FIGURE 56 GLOBAL HIGH-THROUGHPUT SCREENING MARKET ESTIMATION, 2025 698 FIGURE 57 HIGH-THROUGHPUT SCREENING MARKET: COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH) (2025) 699 FIGURE 58 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC: REVENUE ANALYSIS (2025) 700 FIGURE 59 HIGH-THROUGHPUT SCREENING MARKET: INSIGHTS FROM PRIMARIES 701 FIGURE 60 SEGMENTAL MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 702 FIGURE 61 HIGH-THROUGHPUT SCREENING MARKET: CAGR PROJECTIONS 704 FIGURE 62 HTS MARKET: DATA TRIANGULATION 706

同分類最新報告（醫療與生命科學）

查看醫療與生命科學全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們